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Abstract
Background: The ability to reside and proliferate in macrophages is characteristic of several infectious agents that are of
major importance to public health, including the intracellular parasites Trypanosoma cruzi (the etiological agent of Chagas
disease) and Leishmania species (etiological agents of Kala-Azar and cutaneous leishmaniasis). Although recent studies have
elucidated some of the ways macrophages respond to these pathogens, the relationships between activation programs
elicited by these pathogens and the macrophage activation programs elicited by bacterial pathogens and cytokines have
not been delineated.
Methodology/Principal Findings: To provide a global perspective on the relationships between macrophage activation
programs and to understand how certain pathogens circumvent them, we used transcriptional profiling by genome-wide
microarray analysis to compare the responses of mouse macrophages following exposure to the intracellular parasites T.
cruzi and Leishmania mexicana, the bacterial product lipopolysaccharide (LPS), and the cytokines IFNG, TNF, IFNB, IL-4, IL-10,
and IL-17. We found that LPS induced a classical activation state that resembled macrophage stimulation by the Th1
cytokines IFNG and TNF. However, infection by the protozoan pathogen L. mexicana produced so few transcriptional
changes that the infected macrophages were almost indistinguishable from uninfected cells. T. cruzi activated macrophages
produced a transcriptional signature characterized by the induction of interferon-stimulated genes by 24 h post-infection.
Despite this delayed IFN response by T. cruzi, the transcriptional response of macrophages infected by the kinetoplastid
pathogens more closely resembled the transcriptional response of macrophages stimulated by the cytokines IL-4, IL-10, and
IL-17 than macrophages stimulated by Th1 cytokines.
Conclusions/Significance: This study provides global gene expression data for a diverse set of biologically significant
pathogens and cytokines and identifies the relationships between macrophage activation states induced by these stimuli.
By comparing macrophage activation programs to pathogens and cytokines under identical experimental conditions, we
provide new insights into how macrophage responses to kinetoplastids correlate with the overall range of macrophage
activation states.
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Introduction
Macrophages are innate immune cells that respond to a variety
of stimuli [1], [2]. In the early, acute phase of an infection, they are
activated by pathogen-associated molecular patterns (PAMPs),
allowing them to recognize, engulf, and kill invading pathogens
[3]. During the chronic phase of infection, macrophages are
further activated by cytokines secreted by T cells [4]. Interaction
with different PAMPs and cytokines leads to different states of
macrophage activation [5]. These include innate macrophage
activation by microbial products such as LPS through engagement
of pattern recognition receptors (PRRs), classical macrophage
activation by T helper 1 (Th1) cytokines such as interferon gamma
(IFNG) and tumor necrosis factor (TNF), alternative macrophage
activation by T helper 2 (Th2) cytokines such as interleukin-4 (IL-
4) and interleukin-13 (IL-13), and macrophage ‘‘deactivation’’ by
interleukin-10 (IL-10) [6], tumor growth factor beta (TGF-B) or
phagocytosis of apoptotic cells [7] and Fc-receptor (FcR) cross-
linking [1,5,8].
Although many different states of macrophage activation (or
deactivation) have been identified, the phenotypic relationships
between these states remain unclear at a molecular level.
Previous studies have used transcriptional profiling to determine
gene expression in macrophages after they are activated with
bacteria [9,10], type I/II interferons [11], and various intracel-
lular parasites [12,13,14,15,16,17,18,19,20,21,22]. However,
because all of these experiments were performed separately,
they cannot be easily compared and do not directly address the
phenotypic relationship between the different states of macro-
phage activation. To clearly determine how the different states of
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identical culture conditions, we compared the transcriptional
response of bone marrow-derived macrophages to infection by
the kinetoplastid intracellular parasites Leishmania mexicana and
Trypanosoma cruzi, stimulation by the bacterial PAMP lipopoly-
saccharide (LPS), and stimulation by the cytokines IFNG, TNF,
IFNB, IL-4, IL-10, and IL-17. Additionally, in order to
determine whether different types of macrophages respond
differently to activation stimuli, we compared the transcriptional
responses of thioglycollate-elicited peritoneal macrophages with
transcriptional responses of identically treated bone-marrow
derived macrophages following stimulation with IFNG, IL-4,
and TNF.
Methods
Macrophage preparation
Bone marrow-derived macrophages (BMMs) were differentiated
from marrow isolated from femurs and tibias of five 6–8 week-old
C57BL/6 mice (Charles River). The cells were pooled and
cultured in BMM media composed of DMEM + 20% FBS + 10%
3T3 supernatant containing MCSF + 1% Na Pyruvate + 1% L-
glutamine + 1% Penicillin-streptomycin (BMM media). The cells
were differentiated for 6 days, harvested and frozen down in 90%
FBS + 10% DMSO. Cryopreserved macrophages were used so
that all experiments could be conducted using the same batch of
cells. The transcriptional signature of cryopreserved macrophages
was compared to that of fresh macrophages to ensure the quality
of the frozen and thawed BMMs used in these experiments (Figure
S1). The purity of BMMs was confirmed by flow cytometry
analysis using lymphocyte, granulocyte, monocyte, and dendritic
cell surface markers (Figure S2). Replicate experiments were
performed using a separate batch of BMMs derived from a
different set of five C57BL/6 mice. One day before infection,
macrophages were thawed and plated on T25 flasks at a density of
5610
6 cells per flask in BMM media.
Thioglycollate-elicited macrophages were derived by intraper-
itoneal injection of five C57BL/6 mice with 2.5 mL sterile
thioglycollate. Mice were sacrificed 72 h post-injection. Peritoneal
lavage was performed by washing the cavity twice with 5 mL of
PBS. Cells were washed and plated in DMEM + 10% FBS.
Experiments using thioglycollate-elicited macrophages were per-
formed the following day after removal of non-adherent cells by
repeated washing with PBS.
Macrophage infections and stimulation
Leishmania mexicana (strain MNYC/BZ/62/M379) were grown
in M199 media and were washed and resuspended in DMEM +
0.5% FBS for infection. Trypanosoma cruzi (strain CAI-72) were
seeded on a monolayer of BESM (Bovine Embryo Skeletal Muscle)
cells (grown in RPMI + 20% FBS). On day 5 after seeding, the
media on the cells was replaced, and metacyclic trypomastigotes
were collected the following day. T. cruzi parasites were then
washed and resuspended in DMEM + 0.5% FBS for infection. For
L. mexicana and T. cruzi infections, BMMs were washed once with
D-PBS, and their media was replaced with DMEM + 0.5% FBS
containing parasites at a MOI of 10 (an MOI of 1 resulted in only
10% of BMMs infected, and an MOI of 50 resulted in extensive
lysis by 24 h post-infection). Control, uninfected cells received
media without parasites. The flasks were centrifuged at 168xG for
5 m to synchronize the infection. All infections took place over a
24 h time course with RNA collection at 2 h, 6 h, 12 h, and 24 h
time points post-infection. Our data represents three biological
replicates of L. mexicana infection and two biological replicates
of T. cruzi infection. Each biological replicate was performed
independently using macrophages derived from a different group
of mice.
Macrophages were stimulated with 100 ng/mL LPS (Sigma),
100 ng/mL IFNG (R&D Systems), 20 ng/mL IL-4 (Peprotech),
10 ng/mL of IL-10 (Peprotech), 10 ng/mL TNF (R&D Systems),
100 units/mL IFNB (Fischer Scientific), or 100 ng/mL IL-17
(Peprotech). RNA was collected at 2 h, 6 h, 12 h, and 24 h time
points.
Microarray analysis
BMMs were lysed using the TRIzol Reagent (Invitrogen), and
RNA was isolated using the RNeasy Mini Kit (Qiagen). RNA was
then amplified using the Amino Allyl MessageAmp II aRNA
Amplification Kit (Ambion).
All microarray analysis was performed on custom printed
Mouse Exonic Evidence-based Oligonucleotide (MEEBO) Arrays.
Amplified RNA from each sample was hybridized against a pooled
reference consisting of an equal quantity of RNA from all of the
time points within a particular infection time course. The arrays
were scanned using a GenePix 4000B scanner and GenePix PRO
version 4.1 (Axon Instruments/Molecular Devices). The Spot-
reader program (Niles Scientific) was used for array gridding and
image analysis. The resulting data files were uploaded to Acuity
version 4.0 (Molecular Devices), where the raw data was log
transformed, filtered for ‘‘good quality spots’’ (((‘RgnR
‘2(635/
532)’.0.6) AND (‘Flags’.=0))AND((‘F532Mean-b532’.200)
OR (‘F635Median-b635’.200))), normalized to the 0 h control,
and filtered for data present in at least 70% of samples. The
resulting dataset (Dataset S1) was then analyzed for statistically
significant genes using the Statistical Analysis of Microarray (SAM)
software version 3.0 (available at http://www-stat.stanford.edu/
,tibs/SAM/).
Microarrays that were of poor quality (high background, low
foreground) were repeated.
Statistical analysis of microarray data
Pairwise comparisons were performed between infected/
stimulated cells and uninfected cells in order to determine the
Author Summary
Macrophages are a type of immune cell that engulf and
digest microorganisms. Despite their role in protecting the
host from infection, many pathogens have developed
ways to hijack the macrophage and use the cell for their
own survival and proliferation. This includes the parasites
Trypanosoma cruzi and Leishmania mexicana. In order to
gain further understanding of how these pathogens
interact with the host macrophage, we compared macro-
phages that have been infected with these parasites to
macrophages that have been stimulated in a number of
different ways. Macrophages can be activated by a wide
variety of stimuli, including common motifs found on
pathogens (known as pathogen associated molecular
patterns or PAMPs) and cytokines secreted by other
immune cells. In this study, we have delineated the
relationships between the macrophage activation pro-
grams elicited by a number of cytokines and PAMPs.
Furthermore, we have placed the macrophage responses
to T. cruzi and L. mexicana into the context of these
activation programs, providing a better understanding
of the interactions between these pathogens and
macrophages.
Macrophage Response to Pathogens and Cytokines
www.plosntds.org 2 March 2010 | Volume 4 | Issue 3 | e648number of genes significantly affected by the infection/
stimulation and the relative fold changes of these genes. To do
this, the two-class unpaired analysis in SAM was employed with
a false discovery rate (FDR) cutoff of 1% and the condition that
genes must have at least a two-fold change. This stringent FDR
cutoff was chosen in order to focus on genes most highly induced
or repressed by each condition. We treated each time point as an
independent replicate to identify genes that were consistently up
or down-regulated over the 24 h time course. Data for L.
mexicana-infected, T. cruzi-infected, and uninfected BMMs
included 3, 2, and 5 replicate time courses, respectively.
Biological replicates of L. mexicana-infected, T. cruzi-infected, or
uninfected cells were treated as replicates for the purposes of this
analysis.
Multiclass comparisons were also performed between infect-
ed/stimulated cells to determine the number of genes
significantly different between these groups by multiclass
analysis in SAM with a false discovery cutoff of 0.1%. Biological
replicates of L. mexicana and T. cruzi were treated as replicates
for the purposes of this analysis. Once a list of significant genes
was obtained, data was extracted from the total dataset for this
list of significant genes using the Samster tool [23]. Data from
each of the biological replicates were averaged for each
individual time point, filtered for 90% present data, and
hierarchically clustered in Cluster version 3.0 (http://bonsai.
ims.u-tokyo.ac.jp/,mdehoon/software/cluster/software.htm#
ctv). The resulting heat map and trees were visualized using
Java Treeview (available at http://sourceforge.net/projects/
jtreeview/files/).
Gene ontology analysis was performed using the PANTHER
(Protein Analysis Through Evolutionary Relationships) classifica-
tion system (available at http://www.pantherdb.org/). Genes
upregulated by one or multiple stimuli were input into PANTHER
along with a background gene list representing all of the genes
used in the SAM analysis. The biological processes that were over-
represented in the genes of interest were identified and sorted
based on classification type and p-value.
Leishmania and Trypanosoma meta-analysis
For studies that have original array files available in a public
database, those files were obtained and used for processing. For
studies that did not have original array files available, we relied on
the authors’ preprocessed data.
Data were log2 transformed if necessary and arrays were
median centered. Biological and technical replicates, if available,
were averaged for each time point for infected samples. All
infected samples for each probe expression value were then
subtracted by either their paired uninfected sample or the time
zero expression value.
For data generated by this study, each array was median
centered and biological replicates for each time point for both
infected and uninfected were averaged. The corresponding
uninfected expression values were subtracted from infected.
All the columns in the integrated data sets were Z-score
transformed and 90% present filtered. SAM one class analysis was
performed with a 1% FDR cutoff. HUGO identifiers were
converted to Entrez identifiers for functional analysis in PAN-
THER. Methods for supplemental materials have been provided
as Methods S1.
Accession numbers
Microarray data have been deposited in GEO under accession
number GSE20087.
Results
Muted macrophage activation signature by
kinetoplastids relative to LPS
Macrophages respond to pathogens through engagement of
pattern recognition receptors (PRRs), the most well characterized
being the Toll-like receptors (TLRs) [3,24]. Innate activation
through engagement of TLR4 by LPS [25] is well characterized as
being responsible for the majority of the activation program
induced by gram-negative bacteria [9]. However, intracellular
protozoan pathogens induce macrophage responses that are
distinct from their bacterial counterparts [19]. In order to
compare innate macrophage activation programs, bone marrow-
derived macrophages (BMM) were infected with the intracellular
protozoan pathogens, Leishmania mexicana and Trypanosoma cruzi,o r
stimulated with LPS, and host expression responses were analyzed
using microarrays.
In comparison to uninfected control cells, L. mexicana infection
of BMMs resulted in few changes in gene expression (Figure 1B),
which is consistent with other reports describing the subtle nature
of Leishmania infection [13,16,18,19,20,26]. . This lack of response
by the infected macrophages was not due to the absence of
infectivity by the parasites, as both flow cytometry and microscopy
revealed that BMMs were effectively infected by L. mexicana
(Figure S3 A–E).
T. cruzi differed from L. mexicana in that it induced a number of
genes by 24 h post-infection, many of which are known interferon-
stimulated genes (Figure 1A). These results were confirmed by
quantitative real-time PCR (qPCR) analysis for two interferon-
stimulated genes including interferon-induced protein with tetra-
tricopeptide repeats 3 (Ifit3) (Figure S4 A) and interferon activated
gene 205 (Ifi205) (Figure S4 B). This late activation of an IFN
response may correlate with T. cruzi escape from sequestration in a
parasitophorous vacuole into the host cell cytosol and is consistent
with previous microarray studies on T. cruzi infection [17,21,22].
In order to ensure that the transcriptional response to T. cruzi
infection was not being affected by the parasites having been
cultured in BESM cells, we compared the transcriptional signature
of BMMs treated with supernatant from uninfected BESM cells
(mock-infected BMMs) to the uninfected BMMs used in our
experiments. The transcriptional signature of mock-infected
BMMs was highly correlated with the transcriptional signature
of uninfected BMMs (Figure S5).
The transcriptional response to LPS stimulation was distinct
from the responses to either of the intracellular parasites (Figure 1A
and 1B). Out of the 247 genes significantly induced by LPS, only
19 were also induced by T. cruzi, and 1 was also induced by L.
mexicana. Genes induced by both LPS and T. cruzi include Ifit1,
Ifit2, Ifit3, Ifi204, Ifi44, Isg15, Isg20, Gbp3, and Gbp6 (Table 1). The
induction of these interferon response genes is consistent with
studies showing that T. cruzi infection can lead to the induction of
IFNB via signalling through host PRRs [27,28]. However, this
IFN response is quite restricted relative to the response to LPS. As
expected, gene ontology analysis showed that LPS induced genes
enriched for a number of biological processes related to the
immune response such as immunity and defense, interferon-
mediated immunity, cytokine and chemokine mediated signalling
pathway, macrophage-mediated immunity, T-cell mediated im-
munity, JAK-STAT cascade, and granulocyte-mediated immunity
(Table 2). However, genes upregulated by the protozoan
pathogens alone were not significantly enriched for any known
biological processes.
These results indicate that activation by LPS is far more robust
than activation by these intracellular kinetoplastids. L. mexicana
Macrophage Response to Pathogens and Cytokines
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tionally ‘‘silent,’’ suggesting either that the parasite lacks PAMPs,
or that the parasite can inhibit either cellular signalling or host
transcription. Although T. cruzi induced several immune-related
IFN response genes, many of the genes significantly induced by T.
cruzi infection are unnamed (having only a RIKEN designation)
and have unknown functions (Table 1). These results illustrate our
poor understanding of kinetoplastid macrophage interactions
relative to TLR signalling in response to LPS.
Meta-analysis of transcriptional responses to L. mexicana
and T. cruzi
Previous studies have characterized the transcriptional response
to several Leishmania [13,14,16,19,20] and Trypanosoma
[12,15,17,21,22] species using a variety of in vitro and in vivo
infection models. In order to compare our macrophage derived
transcriptional profiling data to previous studies, we performed a
‘‘meta-analysis’’ of all publicly available expression profiling
studies of the host response to Leishmania and Trypanosoma species
(Figures 2 and 3). This analysis showed that the transcriptional
responses of macrophages to L. mexicana and T. cruzi observed in
this study showed commonality with the transcriptional responses
to Leishmania and Trypanosoma species observed in other studies,
despite the important differences in the species of parasites and the
types of mammalian cells characterized.
Specifically, we found that all Leishmania species produced a
transcriptional signature in host cells characterized by very small
numbers of upregulated genes (n=28) and a much larger number
of downregulated genes (n=440) (Figure 2 and Dataset S2). This
observation suggests that infection by Leishmania species may have
a suppressive effect on host transcription. Furthermore, the ability
to infect the host cell in a very ‘‘silent’’ manner, causing minimal
induction of host genes and enabling Leishmania to establish
infection in the host macrophage and remain protected from the
host immune response, may be a phenomenon common to
multiple Leishmania species.
Our meta-analysis indicated that the transcriptional response to
Trypanosoma species was far more robust than the response to
Leishmania species with 781 genes upregulated and 1810 genes
downregulated (Figure 3 and Dataset S3). This was the result of
analyzing in vivo as well as in vitro experiments. The transcriptional
responses to in vivo infection by Trypanosoma congolense (causative
agent of bovine African Trypanosomiasis) [15] showed many
commonalities with the transcriptional response to in vitro infection
by Trypanosoma cruzi [12,17,21,22]. This was surprising since T.
cruzi is an intracellular pathogen that replicates within the host cell
Table 1. Comparison of genes induced by L. mexicana, T. cruzi, and LPS.
Pathogen/pathogen
product Expression ratio (log2) of genes induced by one pathogen/pathogen product only
.3 2–3 1–2
L. mexicana Mt2
T. cruzi Ccdc54, Derl1,
Lce1i
Col16a1, Sycn,
Wipi1
0610010O12Rik, 1700029M20Rik, 1700049J03Rik, 1700113H21Rik, 2300005B03Rik, 2610007O09Rik,
2610034N15Rik, 2810030D12Rik, 9430076C15Rik, A130038J17Rik, Angptl4, Apba2, Atp1b1, BC023814,
Bcl6b, Bhlhe41, Cbfa2t3, Chrna4, Dio2, EG330070, Ebag9, Fibcd1, Hspb8, Ifrd1, Igdcc3, Inpp4a, Mcts2,
Naca, Nat15, Nat6, Olfr380, Osm, Ppm2c, Ppp1r1c, Prss33, Rgs1, Rnf216, Slc25a19, Slc25a22, Snx5,
Sphk1, Tbl3, Tnfrsf9, Tspan17, Ugt1a10, Usp42, Zbtb48
LPS Ccl12, Ch25h,
Cxcl1, Nfkbiz
Adora2b, Bcl2a1c,
Cav1, Ccl4, Ctsc,
Cxcl2, Ddx60, Dusp1,
Ell2, Ets2, Fcgr1, Fos,
Glrx, Gpr85, Gvin1,
Hspa1b, Ifi205, Ifih1,
Jag1, Lcp2, Lpar1,
Marcksl1, Ms4a6b,
Oasl2, Plek, Slco3a1,
Slfn4, Slfn5, Socs3,
Stat1, Trim30
1200003I10Rik, 1200016E24Rik, 9230105E10Rik, AI451617, Abca1, Adar, Agrn, Aif1, Ak3l1, Alas1,
Arhgef3, Ass1, Axud1, Azi2, Bcl2a1b, Bst1, C330023M02Rik, Casp4, Ccdc50, Ccr5, Cd302, Cd40, Cd52,
Cd69, Cdkn1a, Chst7, Clec4e, Clec5a, Clic4, Cpd, Creb5, Ctla2b, Cx3cr1, Cxcl16, Cybb, Cysltr1,
D14Ertd668e, Dck, Dcp2, Ddx58, Dtx3l, Dusp16, Ehd1, Eif2ak2, Epsti1, Errfi1, Fas, Fbxw17, Fgr, Filip1l,
Flrt3, Fmnl2, Fndc3a, Gbp2, Gbp5, Gch1, Gda, Ggct, Glipr2, Gpd2, Gpr84, H2-T9, Herc5, Hivep3, Hmgn3,
Hspa5, Ier3, Ifi203, Ifi35, Ifi47, Ift57, Igtp, Ikbke, Il15, Il15ra, Il18, Il18bp, Il1rn, Irak3, Irf1, Irf7, Irf9, Irgm1,
Itga5, Jak2, Jdp2, Kctd12, Klf7, Lgals9, Lmo4, Lpcat2, Lrrc8c, Ly6a, Ly6e, Magohb, Marco, Mfsd7a,
Mitd1, Mlkl, Mmp13, Mmp14, Msr1, Mx1, Mx2, N4bp1, Nfkbia, Nfkbie, Nmi, Nod1, Nod2, Oas1g, Oas2,
Oasl1, Parp12, Parp14, Parp9, Pcdh7, Pde4b, Phf11, Phlda1, Pid1, Pilra, Pilrb1, Pion, Pla2g16, Pla2g4a,
Plaur, Pml, Pnpt1, Pnrc1, Pols, Ppap2a, Psmb9, Psme1, Psme2, Pstpip2, Rap2c, Rapgef2, Rasgef1b, Rbpj,
Rel, Ripk2, Rnf114, Rnf213, Samd9l, Samhd1, Samsn1, Sdc3, Sdc4, Sgk3, Skil, Sla, Slamf9, Slc15a3,
Slc28a2, Slc2a1, Slc2a6, Slc31a2, Slpi, Smpdl3b, Sp100, Sp110, Spred1, St7, Stap1, Stat2, Stx11, Tank,
Tgfbi, Tlr1, Tmem2, Tmem49, Tnf, Tnfaip3, Tnfsf9, Tor3a, Tpm4, Traf1, Trex1, Trim13, Trim21, Trim34,
Ttc39c, Ube2l6, Usp25, Vasp, Zc3h11a, Zc3h12c, Zfp263, Zfp36, Zfp800, Zufsp
Specific genes induced by more than one pathogen/pathogen product (expression ratio varies)
L. mexicana and T. cruzi 4930578M01Rik
L. mexicana and LPS Ccl7
T. cruzi and LPS Ccl2, Cmpk2, Csf1, Cxcl10, Dhx58, Gbp3, Gbp6, I830012O16Rik, Ifi204, Ifi44, Ifit1, Ifit2, Ifit3, Irgm2, Isg15, Isg20, Mnda, Rsad2,
Usp18
doi:10.1371/journal.pntd.0000648.t001
Figure 1. Comparison of transcriptional responses following infection by the intracellular pathogens Leishmania mexicana and
Trypanosoma cruzi and following stimulation by LPS. A. Unsupervised two-dimensional cluster analysis was performed on genes exhibiting
statistically significant variability between the three conditions, as determined by multiclass SAM (n=636). Replicate experiments of L. mexicana
(n=3) and T. cruzi (n=2) infection were averaged prior to cluster analysis. B. Close-up of gene cluster upregulated by LPS and the 24 h timepoint of T.
cruzi. This cluster includes many interferon-stimulated genes which are not induced by L. mexicana. C. The Venn diagram depicts the overlap of genes
significantly upregulated, as determined by pairwise SAM analysis to uninfected controls, by L. mexicana, T. cruzi, LPS, both T. cruzi and LPS, both T.
cruzi and L. mexicana, and both L. mexicana and LPS. There were no genes significantly upregulated by all three conditions.
doi:10.1371/journal.pntd.0000648.g001
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replicates in the blood stream. It has previously been reported that
T. brucei, an etiological agent of human African Trypanosomiasis
that is related to T. congolense, can activate macrophages via direct
stimulation through its Variable Surface Glycoprotein (VSG) as
well as via induction of host IFNG [29,30,31]. This may partially
explain the similarity in host transcriptional response to T.
congolense and T. cruzi.
In order to determine the biological function of genes induced
or suppressed by the kinetoplastid pathogens, gene ontology
analysis was performed. Very few biological processes were over-
represented at a statistically significant level by the genes induced
or suppressed by Leishmania species. The only over-represented
biological process among genes upregulated by Leishmania was
intracellular signalling cascade (Table 3). The two processes over-
represented in genes downregulated by Leishmania were electron
transport and oxidative phosphorylation (Table 4).
Genes upregulated by Trypanosoma species were involved in a
number of immune-related biological processes, including immu-
nity and defense, interferon-mediated immunity, and macrophage-
mediated immunity (Table 3). This is consistent with the immune-
related nature of T. cruzi-induced genes identified in this study
(Table 2). Genes downregulated by Trypanosoma species were
involved with several metabolic processes including lipid, fatty acid
and steroid metabolism (Table 4).
Distinct signatures of classical, alternative and
deactivation of macrophages
In addition to activation through engagement of PRRs,
macrophages can also be activated by various cytokines. We
therefore compared pathogen recognition programs to cytokine
mediated activation programs in macrophages in order to assess
the relationships between the infections and activation states. To
first compare the relationship between classical activation,
alternative activation, and deactivation of macrophages, we
activated BMM with IFNG, IL-4, or IL-10, respectively, and
compared the transcriptional profiles of these cells to that of
untreated macrophages over a 24 h time course. Genes displaying
significant changes in response to the three cytokine treatments
were identified by performing multiclass analysis using SAM, and
similarities in activation patterns were emphasized by hierarchical
clustering. We found that IFNG, IL-4, and IL-10 produced
distinct activation profiles in macrophages (Figure 4A). An analysis
of genes significantly upregulated by IFNG, IL-4, or IL-10 in
pairwise SAM analyses compared to untreated macrophages
showed that the three cytokines induced mostly non-overlapping
Table 2. Comparison of biological processes induced by L. mexicana, T. cruzi, and LPS.
Biological processes induced by one or more pathogen/pathogen product
P value Biological process Genes
LPS only 1.65E-19 Immunity and defense Adora2b, Aif1, Ccl12, Ccl4, Ccr5, Cd40, Cd69, Clec4e, Clec5a, Cx3cr1, Cxcl1, Cysltr1, Dusp16, Fcgr1, Fgr,
Gbp2, Gbp5, H2-T9, Hspa5, Ier3, Ifi203, Ifi205, Ifi35, Ikbke, Il15, Il15ra, Il18, Il1rn, Irak3, Irf1, Irf7, Isgf3g, Jag1,
Lgals9, Lrrc8c, Marco, Msr1, Nfkbia, Nmi, Nod1, Nod2, Oas1g, Oas2, Oasl1, Oasl2, Pla2g4a, Plaur, Rel,
Samhd1, Sdc4, Sla, Slamf9, Slfn5, Stat2, Tnf
4.41E-13 Interferon-mediated immunity Gbp2, Gbp5, Ifi203, Ifi205, Ifi35, Irf1, Isgf3g, Nmi, Oas1g, Oas2, Oasl1, Oasl2, Stat2
4.63E-06 Cytokine and chemokine
mediated signaling pathway
Ccl12, Ccl4, Ccr5, Cd40, Cx3cr1, Cxcl1, Cxcl2, Fas, Il15, Il5ra, Il18, Il1rn, Tlr1, Tnf, Traf1
2.82E-05 Macrophage-mediated
immunity
Adora2b, Clec42, Cxcl1, Cxcl16, Cxcl2, Fcgr1, Gbp2, Gbp5, Msr1, Sdc4, Stat2
3.45E-05 Apoptosis Adora2b, Arhgef3, Axud1, Bcl2a1c, Casp4, Ddx58, Fas, Ifih1, Ift57, Il15, Jak2, Lgals9, Nfkbia, Nod1, Nod2,
Rel, Ripk2, Sgk3, Socs3, Tnf, Traf1
1.03E-04 Signal transduction Adora2b, Agrin, AI586015, Arhgef3, Azi2, Cav1, Ccl12, Ccl4, Ccr5, Cd40, Creb5, Cx3cr1, Cxcl1, Cxcl2, Cysltr1,
Dusp1, Edg2, Errfi1, Ets2, Fas, Fcgr1, Fgr, Flrt3, Gpr84, Gpr85, Hrasls3, Ifi35, Ikbke, Il15, Il15ra, Il18, Il1rn,
Irak3, Jak2, Lcp2, Marcksl1, Marco, Nfkbia, Nmi, Pcdh7, Pde4b, Ppap2a, Pstpip2, Rap2c, Rapgef2, Rasgef1b,
Rel, Ripk2, Sgk3, Sla, Socs3, Stat2, Tgfbi,Tlr1, Tnf, Traf1, Zfp36
5.73E-04 T-cell mediated immunity Adora2b, Dc40, Cd69, Cxcl1, Cxcl2, H2-T9, Ifi35, Il15ra, Nmi, Sla, Slamf9, Slfn5
1.54E-03 Intracellular signaling
cascade
AI586015, Izi2, Creb5, Cxcl1, Cxcl2, Dusp1, Dusp16, Edg2, Fgr, Ifi35, Il15, Il15ra, Il18, Jak2, Lcp2, Marcksl1,
Nfkbia, Nmi, Pstpip2, Rap2c, Rapgef2, Rel Ripk2, Sgk3, Socs3, Stat2, Zfp36
3.11E-03 JAK-STAT cascade Ifi35, Il15, Il15ra, Il18, Jak2, Nmi, Socs3, Stat2
3.87E-03 NF-kappaB cascade Azi2, Cxcl1, Cxcl2, Ikbke, Nfkbia, Real, Ripk2
6.57E-03 Ligand-mediated signaling Adora2b, Ccl12, Ccl4, Cxcl1, Cxcl2, Edg2, Il15, Il15ra, Il18, Il1rn, Marco, Tnf
9.24E-03 Cell proliferation and
differentiation
AI586015, Aif1, Cdkn1a, Cxcl1, Cxcl2, Errfi1, Ets2, Fgr, Ifi203, Ifi205, Jag1, Jak2, Nfkbia, Pcdh7, Pa2g4a, Rel,
Sdc3, Slfn5, Tgfbi, Trim13
1.61E-02 Granulocyte-mediated
immunity
Ccr5, Cd69, Cx3cr1, Cxcl1, Cxcl2
4.37E-02 Cell surface receptor mediated
signal transduction
Adora2b, AI586015, Cav1, Ccl12, Ccl4, Ccr5, Cd40, Cx3cr1, Cxcl1, Cxcl2, Cysltr1, Edg2, Fas, Flrt3, Gpr84,
Gpr85, Il15, Il15ra, Il18, Il1rn, Irak3, Jak2, Ppap2a, Rapgef2, Rasgef1b, Sla, Tlr1, Tnf, Traf1
4.66E-02 Induction of apoptosis Fas, Ift57, Lgals9, Nod1, Nod2, Ripk2, Tnf, Traf1
T. cruzi and LPS 5.73E-11 Interferon-mediated immunity Cxcl10, Gbp3, Gbp6, Ifit1, Ifit2, Ifit3
9.38E-06 Immunity and defense Ccl2, Csf1, Cxcl10, Gbp3, Gbp6, Ifit1, Ifit2, Ifit3
4.84E-04 Macrophage-mediated
immunity
Csf1, Cxcl10, Gbp3, Gbp6
doi:10.1371/journal.pntd.0000648.t002
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Meta-analysis was performed on the transcriptional response to Leishmania infection using data from this study and 5 additional studies. The
heatmap shows genes upregulated (n=28) and downregulated (n=440) by Leishmania species. List of genes are shown in Dataset S2. hMDC, human
monocyte-derived dendritic cells; hMDM, human monocyte-derived macrophages; mBMM, mouse bone marrow-derived macrophages; hMDMT,
human monocyte-derived macrophages and T cells; mTEM, mouse thioglycollate-elicited macrophages.
doi:10.1371/journal.pntd.0000648.g002
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by IFNG, only 38 were also induced by IL-10, and only 27 were
also induced by IL-4 (Figure 4B). IL-10 and IL-4 only induced 10
of the same genes out of the 138 genes induced by IL-10 and the
108 genes induced by IL-4. The three sets shared only 2 genes in
common.
As expected, IFNG induced a large cluster of interferon-
stimulated genes that were not induced by IL-4 or IL-10 (e.g. Ccl2,
Figure 3. Comparison of transcriptional response to Trypanosoma infection compiled from this study and previous microarray
studies. Meta-analysis was performed on the transcriptional response to Trypanosoma infection using data from this study and 5 additional studies.
The heatmap shows genes upregulated (n=781) and downregulated (n=1810) by Trypanosoma species. List of genes are shown in Dataset S3. hFF,
human foreskin fibroblasts; mKID, mouse whole kidney; mLIV, mouse whole liver; mSPL, mouse whole spleen; HeLa, HeLa cells; mSKN, mouse whole
skin; hSMC, human vascular smooth muscle cells; hCEC, human cardiac microvascular endothelial cells; mBMM, mouse bone marrow-derived
macrophages.
doi:10.1371/journal.pntd.0000648.g003
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Ifi205, Ifi35, Isg20, Stat1, and Stat2). IL-4 induced a number of
novel or unclassified genes (Atp6v0d2, 1810011H11RIK,
2410042D21RIK, Rnf181, Tmem144) and genes not previously
associated with alternative activation (Erg2, Casp6, Chst7, Daglb,
Il1rl2, Rab15, Raly). For example, the PPAR binding protein
(Pparbp/Med1) was induced by IL-4 and likely interacts with
PPARG to act as a co-activator for this nuclear receptor.
Diacylglycerol lipase beta (Daglb) could be involved in metabolic
regulation by alternatively activated macrophages [32].
IL-10 induced its own distinct transcriptional signature in
macrophages. Notable genes induced only by IL-10 include Il4ra,
Ccl6, Il21r, Mmp8, Mmp19, Timp1, and Tlr1 (Table 5). Surprisingly,
there were more genes (n=38) induced in common by both IL-10
and IFNG (eg. Casp4, Ccl12, Ccl4, Irf7, Ly6a, Socs3, Ifi47, Stat3)
than genes (n=10) induced by both IL-10 and IL-4 (eg. Dhrs9,
Fcgr2b, Ptgs1, Tcfec) (Figure 4B). However, one of the genes induced
by IL-10 is Il4ra, which is consistent with a previous study that
suggested exposure to IL-10 enhanced responsiveness to IL-4 [33].
Also of note is the induction of Il21r. IL-21 receptor shows
Table 3. Biological processes induced by Leishmania and Tryapanosoma species as determined by multi-study meta-analysis.
Biological processes induced by protozoan pathogens
Pathogen p-value Biological process Genes
T. cruzi 3.58E-19 Immunity and defense Abcc4, Angptl4, B2m, C3ar1, Ccl2, Ccl5, Ccl7, Ccr1, Ccr2, Cd47, Cd69, Cd86, Cebpb, Chek1, Chek2, Ctss, Cxcl1,
Cxcl16, Cxcl2, Cxcl9, Dph2, F10, Fcer1g, Fos, Gadd45b, Gbp1, Gbp4, Gca, Gsg2, Hla-dma, Hla-e, Hspa1b,
Hspa5, Hspb8, Icam1, Ier3, Ifi16, Ifi30, Ifi35, Ifit1, Ifit2, Ifitm1, Ifitm3, Il15, Il18, Il1a, Il1b, Il1rn, Il4r, Irf1, Irf7, Irf8,
Isgf3g, Klf6, Klrg1, Lair1, Lgals1, Lgals3, Lgals3bp, Lgals9, Litaf, Lrrc59, Lrrc8c, Mocos, Myd88, Ncf2, Nfil3,
Nmi, Nod1, Oasl, Parp3, Pbef1, Pla2g4a, Pla2g7, Plscr1, Ppid, Ppp2r2a, Ppp3cc, Ptgs2, Ptpn22, Pvr, Pvrl2,
Rnpep, Samhd1, Slamf8, Slc11a1, Slfn5, Sod2, Stat2, Stat3, Tap1, Tap2, Tapbp, Tbk1, Tcirg1, Thbs1, Tnf,
Tnfaip2, Tnfrsf1b, Was, Xbp1
1.56E-08 Cytokine and chemokine
mediated signaling pathway
Ccl2, Ccl5, Ccl7, Ccr1, Ccr2, Cx3cl1, Cxcl1, Cxcl2, Cxcl9, Il15, Il18, Il1a, Il1b, Il1rn, Il4r, Osm4, Ptpn2, Sirpa, Tlr1,
Tlr2, Tlr3, Tlr4, Tnf, Tnfrsf1b, Traip
2.65E-08 Interferon-mediated immunity Cxcl9, Gbp1, Gbp4, Ifi16, Ifi35, Ifit1, Ifit2, Irf1, Irf7, Irf8, Isgf3g, Nmi, Oasl, Slamf8, Stat2
1.19E-03 Macrophage-mediated immunity Cxcl1, Cxcl16, Cxcl2, Cxcl9, Gbp1, Gbp4, Il1a, Il1b, Lgals3bp, Litaf, Stat2, Tnfaip2
1.68E-03 Cytokine/chemokine mediated
immunity
Ccl2, Ccl5, Ccl7, Ccr1, Ccr2, Cxcl9, Il1a, Il1b, Tbk1, Tnfaip2, Tnfrsf1b
5.32E-03 Granulocyte-mediated immunity Ccr1, Ccr2, Cd47, Cd69, Cxcl1, Cxcl2, Gca, Ncf2
1.18E-02 T-cell mediated immunity B2m, Cd69, Cd86, Ctss, Cxcl1, Cxcl2, Hla-dma, Hla-e, Ifi30, Ifi35, Nmi, Slamf8, Slfn5, Tapbp, Tcirg1
2.28E-02 JAK-STAT cascade Ifi35, Il15, Il18, Il4r, Jak2, Nmi, Ptpn2, Stambp, Stat2, Stat3
2.69E-02 DNA replication Cdc6, Fen1, Gins1, Hmgn3, Lig1, Mcm3, Mcm4, Mcm5, Mcm6, Orc6l, Pole, Prim2a, Rfc3, Rfc4, Rfc5, S100a11,
Top2a, Wrn
3.00E-02 Ligand-mediated signaling Ccl2, Ccl5, Ccl7, Cd86, Cxcl1, Cxcl2, Cxcl9, Edg5, Grn, Il15, Il18, Il1a, Il1b, Il1rn, Il4r, Lair1, Pbef1, Slc1a3, Tnf
4.79E-02 Other immune and defense Cxcl9, Gsg2, Lgals1, Lgals3, Lgals9, Lrrc59, Lrrc8c, Myd88, Nod1, Pla2g4a, Pla2g7, Ptpn22, Rnpep, Tnfaip2
L. mexicana 1.30E-02 Intracellular signaling cascade Cxcl1, Cxcl2, Dusp1, Gadd45g, Jak3, Pik3c2a, Stam2
doi:10.1371/journal.pntd.0000648.t003
Table 4. Biological processes suppressed by Leishmania and Tryapanosoma species as determined by multi-study meta-analysis.
Biological processes repressed by protozoan pathogens
Pathogen p-value Biological process Genes
T. cruzi 2.69E-04 Lipid, fatty acid and
steroid metabolism
Aacs, Abca3, Abcd3, Acad8, Acadm, Acadsb, Acadvl, Acbd4, Acly, Acot11, Acox1, Acp6, Acsl1, Adipor1, Adipor2,
Agpat2, Apoe, Ascc1, Atp11c, C2orf43, C7orf10, Cav1, Cav2, Cdipt, Chkb, Cmas, Cpt2, Crat, Crot, Cyb5a, Cyp2e1,
Dci, Decr2, Dgat1, Dgka, Ebpl, Echdc3, Elovl5, Ephx1, Fasn, Fdx1, Gba2, Gcdh, Gpam, Gpx1, Gpx4, Habp4, Hadh,
Hadha, Hmgcl, Hmgcs2, Hpgd, Hsd17b4, Hsdl1, Impad1, Ivd, Kiaa0274, Lpgat1, Lpin1, Mcat, Mgll, Mmd, Mmd2,
Mtmr3, Nudt3, Nudt4, Osbpl2, Osbpl5, Osbpl9, Pccb, Pcyt1a, Pcyt2, Pex19, Phyh, Pik4ca, Pip5k1c, Plscr4, Pmvk,
Ppap2b, Ppapdc2, Ppara, Prkab1, Prkab2, Prkag1, Pten, Rnpepl1, Sacm1l, Sc5dl, Scap, Scarb1, Sec14l2, Slc27a4,
Slc37a4, Sorl1, Srebf1, Srebf2, St3gal2, Stard10, Stard4, Sult1c1, Tmem23, Tns1, Usf2
1.85E-02 Fatty acid metabolism Aacs, Acad8, Acadm, Acadsb, Acadvl, Acot11, Acox1, Acsl1, Adipor1, Adipor2, Cpt2, Crat, Crot, Cyp2e1, Dci,
Decr2, Echdc3, Elovl5, Fasn, Gcdh, Hadh, Hadha, Hmgcl, Ivd, Mcat, Mmd, Mmd2, Pccb, Phyh, Prkag1, Rnpepl1,
Slc27a4
1.91E-02 Amino acid metabolism Acy1, Adi1, Aga, Akap13, Aldh5a1, Aldh6a1, Arhgef12, Arhgef18, Arhgef3, Asnsd1, Bcat2, Bckdhb, Bckdk, Cbs,
Ccbl1, Cpt2, Crat, Crot, Csad, Ctbp1, Dph5, Fah, Fahd1, Fahd2a, Fasn, Fbx08, Glud1, Glul, Grhpr, Hibadh, Ilvbl,
Kmo, Kynu, Me1, Nadsyn1, Nfs1, Papss1, Papss2, Qdpr
L. mexicana 1.25E-03 Electron transport Atp5j2, Blvra, Cat, Cox5b, Cox6a1, Cox7a2l, Cyb5r1, Ndufa2, Ndufa5, Ndufa6, Ndufa9, Ndufb5, Ndufb8, Ndufs3,
Ndufv1, Sdha, Sdhb, Sdhc, Tbxas1, Txn2, Uqcr, Uqcrb, Uqcrc1, Uqcrc2, Uqcrh
3.25E-03 Oxidative phosphorylation Atp5j2, Cox5b, Cox6a1, Ndufa2, Ndufa5, Ndufa6, Ndufa9, Ndufb5, Ndufb8, Ndufs3, Ndufv1, Sdha, Sdhb, Uqcr,
Uqcrb, Uqcrh
doi:10.1371/journal.pntd.0000648.t004
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alpha and has been shown to augment alternative macrophage
activation [34], further suggesting that IL-10 may indirectly
promote alternative activation by increasing sensitivity to IL-4, IL-
13 and IL-21.
In order to determine what biological processes and pathways
are induced by each of the cytokines, we performed gene ontology
analysis on genes upregulated by only one cytokine as well as on
genes upregulated by more than one cytokine (Table 6). Gene
ontology analysis of the genes induced by IL-4 alone did not reach
statistical significance for any biological process classification. This
is likely due to the smaller number of genes in this category as well
as the fact that many of these genes are novel and have unknown
functions, highlighting the need for additional work on IL-4
signaling in macrophages and its associated gene expression
patterns. In contrast to IL-4 treatment, IL-10 and IFNG treatment
produced unique gene lists that were enriched in the biological
processes of immunity and defense and cytokine and chemokine
mediated signaling pathways (Table 6). IL-10 activated genes were
also enriched in lipid and fatty acid transport, while IFNG
activated genes were enriched in interferon mediated immunity, T
cell-mediated immunity, ligand-mediated signaling, signal trans-
duction, macrophage-mediated immunity, and apoptosis (Table 6).
As noted above, IFNG and IL-10 induced genes that fall into
similar categories and were quite distinct from IL-4 induced genes.
IFNG activation signature in macrophages is more similar
to TNF than IFNB
TNF and IFNB contribute to the early inflammatory cytokine
milieu and have both been shown to induce classical macrophage
activation [1]. In contrast to IFNG, which is produced mainly by
lymphocytes, TNF and IFNB are cytokines that are often
produced at the very early acute stages of an immune response
by many other cell types [35,36]. While the IFNs initiate a
signalling cascade that involves the JAK family of tyrosine kinases
and STAT family of transcription factors [37,38], TNF signals
through TRAFs to activate the transcription factors NF-kB and
AP-1 [39,40]. Signalling via the IL-17 receptor has also been
shown to occur through the adaptor molecule TRAF6 leading to
the activation of NF-kB and AP-1, suggesting it may activate
macrophages in a manner similar to TNF [41,42,43].
To determine the macrophage activation signatures following
stimulation with TNF, IFNB, and IL-17 and their relationship
with IFNG, macrophages were activated by IFNB, TNF and IL-
17. To identify genes upregulated and downregulated by
activation through these cytokines, the resulting data was analyzed
by SAM via two-class unpaired statistical comparisons against
untreated control macrophages. To compare gene expression
changes between all of the different cytokines, multiclass SAM
analysis followed by hierarchical clustering analysis was performed
on the expression profiles of macrophages activated by IFNG,
IFNB, TNF, and IL-17.
We found that the response to IFNG was most related to the
response to TNF, whereas IFNB and IL-17 produced more
Figure 4. Comparison of transcriptional responses to classical
activation, alternative activation, and macrophage deactiva-
tion. A. Unsupervised two-dimensional cluster analysis was performed
on genes exhibiting statistically significant variability between the three
conditions, as determined by multiclass SAM (n=1489). B. The Venn
diagram depicts the overlap of genes significantly upregulated, as
determined by pairwise SAM analysis to unstimulated controls, by IFNG,
IL-4, IL-10, both IFNG and IL-4, both IFNG and IL-10, both IL-4 and IL-10,
and all three cytokines.
doi:10.1371/journal.pntd.0000648.g004
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that the interferons signal through overlapping JAK-STAT
pathways, while TNF signals through a distinct NF-kB pathway.
An analysis of the genes induced by TNF revealed a number of
interferon-stimulated genes, suggesting that TNF may be inducing
expression of an interferon by macrophages. This is consistent with
a previous study which showed that TNF induces IFNB
production in macrophages [44]. To determine whether TNF
induced IFNB, we measured the amount of IFNB mRNA in TNF-
stimulated cells by qPCR. TNF-stimulated macrophages upregu-
lated IFNB transcript starting at 2 h after stimulation and peaking
at 6 h after stimulation (Figure S7 A). Although this explained why
TNF induced the expression of interferon-stimulated genes, it did
not explain why the macrophage response to TNF is more similar
to the response to IFNG than to IFNB. Further analysis of the
array data revealed that IFNG stimulation induced expression of
TNF (Tables 5 and 7), while IFNB stimulation did not. To confirm
this finding, we measured the expression of TNF in cells stimulated
by IFNG or IFNB by qPCR. We found that IFNG induced
significant levels of TNF transcript by 2 h after stimulation, while
IFNB failed to induce TNF expression (Figure S7 B). In addition,
we found through cytometric bead analysis (CBA) of culture
supernatants that IFNG-stimulated macrophages secreted high
levels of TNF protein by 6 h after stimulation (Figure S7 C). The
level of TNF peaked at 12 h post-stimulation at approximately
400 pg/mL. These selective interactions between cytokine signal-
ling pathways explain the similarity in gene expression observed
for cytokines with disparate signalling pathways.
There was a significant overlap between the genes up-regulated
by IFNG, IFNB, and TNF (Figure 5B). Of the 219 genes induced
by TNF, 164 were also induced by IFNG, consistent with the
observation that IFNG induced TNF production by macrophages
(Figure S7 B–C) as described above. Genes induced by both TNF
and IFNG included Cxcl1, Ifi47, Mmp14, Nod2, Socs3, and Tnf
(Table 7). IFNG and IFNB also up-regulated many of the same
genes (n=177) including Ccl12, Ifi205, Irf7, Nod1, and Stat2
(Table 7). A subset of these genes (n=82) were induced by all three
of the cytokines, including Ccl4, Ccl5,Gbp3, Gbp5, Gbp6, Ifi203,
Table 5. Comparison of genes induced by IFNG, IL-4, and IL-10.
Expression ratio (log2) of specific genes induced by one cytokine only
Cytokine .3 2–3 1–2
IFNG Ccl2, Ccl7, Cd69,
Gbp3, Gbp5,
Gbp6, Ifi44,
Ifit2, Igtp, Mnda,
Rgs1, Serpina3f,
Slamf8, Slco3a1
Acsl1, B230207M22Rik,
Ccl5, Ccnd2, Ccrl2,
Cd83, Cd86, Cmpk2,
Ctsc, Cxcl1, Cxcl10,
D14Ertd668e, Denr,
Ets2, Fcgr4, Fzd7,
Gch1, Gdap10, Ggct,
Herc5, I830012O16Rik,
Ifi204, Ifih1, Ifit1, Ifit3,
Il1rn, Irgm1, Irgm2,
Jdp2, Lmo4, Mx1,
Nod1, Oasl2, Parp14,
Phf11, Pla2g16,
Rnf213, Rsad2, Slamf7,
Slc7a11, Slfn4, Slfn5,
Stx11, Tnf, Tnfaip3,
Usp18, Wars
0610038D11Rik, 1110002E22Rik, 1110038F14Rik, 1190002H23Rik, 1200003I10Rik, 1200009I06Rik, 2010106G01Rik,
2210012G02Rik, 2310007H09Rik, 2310016C08Rik, 2310058D17Rik, 2410039M03Rik, 4921509J17Rik, 4930403L05Rik,
4930427A07Rik, 5031414D18Rik, 9030607L20Rik, 9130209A04Rik, 9230105E10Rik, 9930023K05Rik, A930033M14Rik,
AA960436, AI451617, Acsl5, Adar, Agfg1, Ak3l1, Ampd3, Ankrd57, Arhgef3, Armc8, Arrdc4, Asns, Ass1, Atf4, Atp8a2,
B4galt3, B4galt5, BB123696, BC006779, BC013712, BC046404, Bambi-ps1, Basp1, Bat2d, Bcl2a1b, Bcl2a1c, Bfar,
Birc2, Birc3, Bmi1, Bst2, Car13, Ccdc25, Ccl3, Cd1d1, Cdc42ep2, Chac1, Chmp4b, Ciita, Clcn7, Clec2d, Clec4e, Creb1,
Creb5, Crem, Csnk1d, Csprs, Cxcl16, Cxcl2, Cybb, Daxx, Dcp2, Ddit3, Ddx58, Ddx60, Dhx58, Dio2, Dlk1, Dock4, Dtx3l,
Dusp16, Dusp28, Egr1, Ehd1, Eif2ak2, Emr1, Enc1, Etnk1, Fabp3, Fam102b, Fam46c, Fam82a2, Farp2, Fas, Fndc3a,
Foxred1, Glipr2, Glrp1, Gna13, Gnaq, Gpd2, Gpr141, Gtf2h1, Gtpbp2, Gvin1, H2-Q7, H2-T10, H2-T23, H2-T24, Haghl,
Herc3, Hk1, Hk2, Hspa2, Icam1, Ifi203, Ifi205, Ifi35, Ifrd1, Il12rb2, Il15, Il15ra, Il27, Inpp5b, Insig1, Irak2, Irf8, Isg20,
Itgav, Jak2, Katna1, Kdr, Kitl, Lass6, Lcp2, Lgals9, Lpar1, Lrrc14, Lrrc8c, Ltbp1, Ly6c1, M6pr, Mafk, Mdk, Mdm2,
Mfsd7a, Mitd1, Mlkl, Mmp14, Mobkl1a, Mov10, Mpzl1, Mt2, Mtmr14, Mx2, Myd88, Nampt, Nfkb1, Nfkbie, Nmi,
Nod2, Nr3c1, Nrp2, Nsbp1, Nt5c3, Oas1b, Oas1g, Oas2, Oasl1, Obfc2a, Ogfr, Olfr319, Olfr635, Otud1, P4ha1, Parp12,
Parp9, Pcgf5, Pcmtd1, Pde4b, Peli1, Pfkfb3, Pfkp, Phlda1, Phlpp, Pla2g4a, Plaur, Plk2, Pml, Pmm2, Poldip3, Ppa1,
Ppap2a, Ppap2b, Ppfibp2, Ppm1k, Ppp1r15b, Ppp2r2a, Prkx, Prpf38a, Psat1, Psmb10, Psmb9, Pstpip2, Ptafr,
Rab11fip1, Rab12, Rab20, Ralgds, Rasa4, Rasgef1b, Rassf1, Rbm7, Rgl1, Rnf114, Rnf135, Rnf14, Rnf34, Samd9l,
Samhd1, Sco1, Sema3c, Serpinb1a, Sestd1, Sgk1, Slc15a3, Slc2a6, Slc30a1, Slc31a1, Slc31a2, Slc3a2, Slc43a3,
Slc6a9, Slfn1, Slfn2, Smpdl3b, Snx20, Soat2, Sp100, Sp110, Spata13, Spred1, Spred2, Spty2d1, Srgn, Srxn1, St3gal1,
St3gal5, St6galnac4, St7, Stam2, Stat1, Stat2, Stk19, Stoml1, Stradb, Stx2, Tank, Tap1, Tapbp, Tapbpl, Tbc1d9,
Tgm2, Tgoln1, Tgs1, Tm9sf4, Tmcc3, Tmem132a, Tmem2, Tnfrsf1a, Tnfrsf1b, Tnfsf9, Tor3a, Tpm4, Traf1, Trafd1,
Trex1, Trib3, Trim13, Trim21, Trim30, Trim34, Trps1, Ttc39b, Ttc9c, Tyk2, Ubash3b, Ubd, Ube2l6, Ube2z, Ugcg,
Usp12, Wdr20b, Wdr37, Wnt9a, Xkr8, Zbtb5, Zc3h12c, Zc3hav1, Zc3hc1, Zcchc2, Zfp429, Zfp800, Znfx1, Zufsp, Zyx
IL-4 Atp6v0d2, Egr2 1810011H11Rik, 2410042D21Rik, Acad8, Ak2, Arfgap2, Atic, Atp6v0a1, Baiap2, Batf3, Bcar3, Brd4, Brwd1,
C030015D21Rik, Casp6, Chst7, Ctdp1, Cyp20a1, Daglb, Dusp4, ENSMUSG00000055697, Fam63a, Fchsd2, Fem1c,
Flcn, Fyn, Herpud1, Herpud2, Hsph1, Il11ra1, Il1rl2, Il6st, Ipmk, Itgax, Itgb1, Lsm14b, Mat2a, Med1, Med15, Mettl9,
Mgl1, Mgl2, Mllt3, Mybbp1a, Nat13, Necap1, OTTMUSG00000016703, P2ry1, Pcyt2, Pde12, Peo1, Pnpla8, Pparg,
Ppp2r3a, Prosc, Prpf19, Prps1, Psmc4, Ptcd2, Rab15, Raly, Rnf181, Rragd, Sh3kbp1, Slc25a13, Slc30a4, Slc39a8,
Tmco3, Tmed9, Tmem144, Ubqln1, Wdr45l
IL-10 Ednrb, Il4ra Gda, Tnfsf14 4930435H24Rik, 4930471M23Rik, 5430427O19Rik, 6430527G18Rik, AB124611, Abcg1, Acat2, Aldh3b1, Aldoa,
Ap1b1, Apoc2, Auh, BB031773, Bcl3, C1qb, C1qc, Ccl6, Ccr5, Cd74, Cdk2ap2, Cdkn2d, Cebpb, Coro1a, Cox7a2l, Ctsa,
Cyth4, EG625174, Enpp1, Eps8, Fabp4, Fcgr1, Fcgr3, Fdps, Flot1, Fxc1, Fxyd2, Gbp2, Gcnt2, H2-DMa, H2-gs10,
Hist1h3a, Hlx, Hmox1, Hsd17b10, Htra1, Ifitm2, Ifitm6, Il21r, Kif3a, Lilrb4, Lrrc25, Ly6e, Mafb, Malat1, Mefv, Mmp19,
Mmp8, Mvd, Naaa, Ndrg1, Nfil3, Olfm1, Pdpn, Pld3, Plek, Pltp, Ppil2, Psme1, Ptpn1, Rac2, Sbno2, Sirpb1a, Smox,
Spint1, Tcirg1, Tgfbi, Tha1, Timp1, Tle3, Tlr1, Tm2d2, Tmem49, Tmem8, Tnfaip8l2, Trim46, Tspan13, Tspo, Zic4
Specific genes induced by more than one cytokine (expression ratio varies)
IFNG and IL-4 Arg2, Cd274, Ch25h, Cish, Clic4, Csf1, Flrt2, Flt1, Fmnl2, Gigyf2, Klf4, Maea, Mmp13, Psmd2, Rai12, Rars, Rel, Ripk2, Rnf19b, Snn, Socs1, Stam,
Tlr4, Vegfc, Yme1l1
IFNG and IL-10 1200016E24Rik, 4933412E12Rik, Axud1, Btg1, Casp4, Ccl12, Ccl4, Cd40, Cdkn1a, F10, Fam26f, Fgl2, Flrt3, Gadd45b, Gsdmd, H2-Aa, H2-Ab1,
H2-Eb1, Ier3, Ifi47, Igf2bp2, Il18bp, Il1b, Irf7, Ly6a, Ly6f, Mcoln2, Mxd1, Nfkbiz, Pgs1, Psmb8, Saa3, Slc28a2, Socs3, Stat3, Zfp36
IL-4 and IL-10 Csf2rb, Dhrs9, Fcgr2b, Mrc1, Ncoa4, Ptgs1, Rab3il1, Tcfec
IFNG and IL-4 and IL-10 Irf1, Pim1
doi:10.1371/journal.pntd.0000648.t005
Macrophage Response to Pathogens and Cytokines
www.plosntds.org 11 March 2010 | Volume 4 | Issue 3 | e648Ifi204, Ifi35, Ifi44, Ifih1, Ifit1, Ifit2, Ifit3, Irf1, Isg20, Mmp13, Socs1,
and Stat1 (Table 7). A number of genes were induced by only one
cytokine; for example, the pattern recognition receptors Tlr3, Tlr7,
and Tlr8 are only induced by IFNB and not by TNF or IFNG.
Gene ontology analysis was performed on genes up-regulated by
only one cytokine as well as on genes up-regulated by more than
one cytokine. IFNG, TNF, and IFNB function in many of the
same biological processes, including immunity and defense,
interferon-mediated immunity, and macrophage-mediated immu-
nity (Table 8). Although most of the enriched biological processes
are shared between the three cytokines, a few are specific to
individual cytokines. For example, only IFNG induced genes
enriched for MHCII-mediated immunity (Table 8). TNF induced
genes enriched for several unique processes such as neurogenesis
and ectoderm development. IFNG and IFNB both induced genes
in the biological processes of proteolysis and protein metabolism
and modification, but TNF did not (Table 8).
Unexpectedly, IL-17 produced minimal transcriptional changes
in comparison to the other cytokines. Only 7 genes were positively
regulated based on pairwise SAM analysis against unstimulated
controls (Table 9). Although several of the upregulated genes were
genes also induced by IFNG, IFNB, and TNF (e.g. Cxcl1, Oasl2,
Phf11), the magnitude of the upregulation was much lower. In
order to determine whether the paucity of transcriptional
responses to IL-17 was due to the lack of IL-17 receptor
expression on BMMs, we stained BMMs with an anti-IL-17
receptor antibody for analysis by flow cytometry (Figure S8). We
found that BMMs do express the IL-17 receptor, suggesting that
transcriptional responses to IL-17 may require additional co-
stimulation or pre-stimulation by another cytokine or antigen.
Relationship between pathogen and cytokine mediated
macrophage activation
The PAMPS expressed by intracellular protozoans such as T.
cruzi and L. mexicana are much less well characterized than those of
bacterial pathogens. Comparing the transcriptional responses of
macrophages infected with kinetoplastids to those of macrophages
stimulated by various cytokines may provide insights as to the
types of receptors these pathogens engage and the signalling
pathways they initiate. In order to compare the transcriptional
changes associated with cytokine signalling and intracellular
pathogen infection, cluster analysis was performed on all cytokine
and pathogen arrays. This showed that innate activation by LPS
was most closely related to classical activation by the cytokines
IFNG and TNF (Figure 6). Activation by the cytokine IFNB was
Table 6. Comparison of biological processes induced by IFNG, IL-4, and IL-10.
Biological processes induced by one or more cytokine
P value Biological process Genes
IFNG only 4.63E-18 Interferon-mediated immunity Cxcl10, Gbp3, Gbp5, Gbp6, Ifi203, Ifi205, Ifi35, Ifit1, Ifit2, Ifit3, Irf8, Nmi, Oas1b, Oas1g, Oas2, Oasl1,
Oasl2, Slamf7, Slamf8, Stat2
5.23E-16 Immunity and defense C2ta, Ccl2, Ccl3, Ccl5, Ccl7, Ccrl2, Cd1d1, Cd69, Cd86, Clec2d, Clec4e, Cxcl1, Cxcl10, Cxcl16, Cxcl2,
Dusp16, Fcgr3a, Gbp2, Gbl5, Gbl6, H2-D4, H2-Q7, H2-T24, Haghl, Hspa2, Icam1, Ifi203, Ifi205, Ifi35, Ifit1,
Ifit2, Ifit3, Il12rb2, Il15, Il15ra, Il1rn, Irak2, Irf8, Lgals9, Lrrc8c, Myd88, Nfkb1, Nmi, Nod1, Nod2, Oas1b,
Oas1g, Oas2, Oasl1, Oasl2, Pbef1, Phlpp, Pla2g4a, Plaur, Ppp2r2a, Ptafr, Rgs1, Samhd1, Slamf7, Slamf8,
Slfn5, Stat2, Tap1, Tapbp, Tapbpl, Tnf, Tnfrsf1a, Tfnrsf1b
6.48E-06 T-cell mediated immunity C2ta, Cd1d1, Cd69, Cd86, Cxcl1, Cxcl2, H2-D4, H2-Q7, H2-T24, Ifi35, Il15ra, Nmi, Slamf7, Slamf8, Slfn5,
Tapbp, Tapbpl, Tnfrsf1a
4.49E-05 Ligand-mediated signaling Ccl2, Ccl3, Ccl5, Ccl7, Cd86, Cxcl1, Cxcl10, Cxcl2, Edg2, Il12rb2, Il15, Il15ra, Il1rn, Kitl, Mdk, Pbef1, Tnf,
Tnfrsf1a, Wnt9a
7.97E-05 Cytokine and chemokine
mediated signaling pathway
Ccl2, Ccl3, Ccl5, Ccl7, Ccrl2, Cxcl1, Cxcl10, Cxcl2, Fas, Il12rb2, Il15, Il15ra, Il1rn, Tnf, Tnfrsf1a, Tnfrsf1b,
Traf1
2.34E-04 Signal transduction 0710001B24Rik, 2010206G01Rik, 9130017C17Rik, Arhgef3, Ccl2, Ccl3, Ccl5, Ccl7, Ccrl2, Cd86, Creb1,
Creb5, Crem, Csnk1d, Csprs, Cxcl1, Cxcl10, Cxcl2, Dock4, Dusp16, Edg2, Emr1, Ets2, Fabp3, Fas, Fcgr3a,
Gna13, Gnag, Gpr141, Hrasls3, Hrb, Icam1, Ifi35, Il12rb2, Il15, Il15ra, Il1rn, Inpp5b, Irak2, Jak2, Kdr, Kitl,
Lcp2, Ltbp2, M6pr, Mdk, Myd88, Nfkb1, Nmi, Nrp2, Ogfr, Olfr319, Pbef1, Pde4b, Plk2, Ppap2a, Ppap2b,
Ppm1k, Prkx, Pstpip2, Ptafr, Rab12, Rab20, Ralgds, Rasa4, Rasgef1b, Rassf1, Rgl1, Rgs1, Rnf14, Sema3c,
Sgk, Spata13, Stam2, Stat2, Tnf, Tnfrsf1a, Tnfrsf1b, Traf1, Trib3, Tyk2, Wnt9a
2.55E-03 Macrophage-mediated immunity Clec4e, Cxcl1, Cxcl10, Cxcl16, Cxcl2, Fcgr3a, Gbp3, Gbp5, Gbp6, Stat2, Tnfrsf1a
2.74E-02 Cytokine/chemokine mediated
immunity
Ccl2, Ccl3, Ccl5, Ccl7, Ccrl2, Cxcl10, Tnfrsf1a, Tnfrsf1b
2.98E-02 Apoptosis Arhgef3, Bcl2a1c, Birc2, Birc3, D11Lgp2e, Ddx58, Fas, Ifih1, Il15, Jak2, Lgals9, Mdm2, Nfkb1, Nod1,
Nod2, Rassf1, Sgk, Tnf, Tnfrsf1a, Traf1, Ube2z
IL-10 only 1.20E-05 Immunity and defense C1gb, C1gc, Ccl6, Ccr5, Cd74, Cebpb, Fcgr1, Fcgr3, Gbp2, H2-DMa, H2-Q5, Ifitm2, Ifitm6, Il21r, Il4ra,
Nfil3, Ppil2, Tcirg1, Tnfaip8l2, Tnfsf14
7.47E-03 Cytokine and chemokine
mediated signaling pathway
Ccl6, Ccr5, Il4ra, Ptpn1, Sirpb1, Tlr1, Tnfsf14
3.40E-02 Lipid and fatty acid transport Abcg1, Apoc2, Fabp4, Pltp, Tspo
IFNG and IL-10 1.04E-06 Immunity and defense Ccl12, Ccl4, Cd40, F10, Gadd45b, H2-Aa, H2-Ab1, H2-Eb’, H2-T23, Ier3, Il1b, Irf7, Saa3, Stat3
1.67E-03 MHCII-mediated immunity H2-Aa, H2-Ab1, H2-Eb1
5.47E-03 T-cell mediated immunity Cd40, H2-Aa, H2-Ab1, H2-Eb1, H2-T23
1.52E-02 Apoptosis Axud1, Casp4, Gadd45b, Il1b, Socs3, Stat3
doi:10.1371/journal.pntd.0000648.t006
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study showing that macrophage responses to LPS and immune
complexes are more similar to classical activation than to
alternative activation [45]. The similarity between LPS and
TNF can also be attributed to the induction of Tnf in macrophages
stimulated with LPS (Table 1). Furthermore, flow cytometry
analysis showed that TNF was produced by approximately 15% of
BMMs 4 h post-stimulation by LPS (Figure S9).
Innate macrophage activation by the protozoan pathogens
branched separately from classical activation. Instead, macro-
phages infected by T. cruzi and L. mexicana clustered with
macrophages stimulated by IL-17, IL-10, and IL-4. This suggests
that infection by kinetoplastids results in a macrophage activation
state that is more similar to alternative macrophage activation and
macrophage deactivation than to classical macrophage activation.
Although there are signs of an IFN response at later time points of
T. cruzi infection, this signature is not strong enough to affect the
overall clustering results.
The transcriptional response of bone marrow-derived
macrophages differs from that of identically treated
thioglycollate-elicited macrophages
Historically, intra-peritoneal injection with Brewer’s thioglycol-
late medium has been a convenient method to procure large
numbers of macrophages for use in functional and biochemical
studies [46]. More recently, bone marrow-derived macrophages
have become widely used for such experiments. The transcrip-
tional profile of these two types of macrophages may be divergent.
Since all transcriptional profiling studies to date have been
performed using a single type of macrophage, it is unknown how
transcriptional responses may vary depending on the type of
macrophage used.
To address this question, we treated BMMs and thioglycol-
late-elicited macrophages (TM) with the cytokines IFNG, TNF,
and IL-4 and compared their transcriptional responses. We used
hierarchical clustering analysis to identify the conditions in
which the transcriptional responses were most similar. We found
that arrays clustered based on the type of macrophage instead of
t h et y p eo fc y t o k i n es t i m u l a t i o n( F i g u r e7 A ) .I no r d e rt o
determine whether this was due to differential expression of
background transcripts or differential response to cytokine
stimulation, we performed multiclass SAM analysis on only
the bone marrow macrophage arrays. The genes identified from
this analysis (n=168) were then extracted from the thioglycol-
late macrophage dataset, and a hierarchical clustering analysis
was performed (Figure 7B). We found that the arrays clustered
based on the cytokine instead of the macrophage type, with the
IFNG and TNF arrays clustering together and away from the
IL-4 arrays irrespective of macrophage type. A similar result was
obtained when the cluster analysis was performed on genes
identified by a multiclass SAM analysis of only the thioglycollate
arrays (n=124) (Figure 7C). This shows that although the
baseline transcriptional signatures of bone marrow-derived and
Figure 5. Comparison of transcriptional responses to cytokines
implicated in classical macrophage activation. A. Unsupervised
two-dimensional cluster analysis was performed on genes exhibiting
statistically significant variability between stimulation with IFNG, IFNB,
TNF, and IL-17, as determined by multiclass SAM (n=773). B. The Venn
diagram depicts the overlap of genes significantly upregulated, as
determined by pairwise SAM analysis to unstimulated controls, by IFNG,
IFNB, TNF, both IFNG and IFNB, both IFNG and TNF, both IFNB and TNF,
and all three cytokines.
doi:10.1371/journal.pntd.0000648.g005
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types of macrophages respond to cytokines in a relatively similar
fashion.
In order to determine more specific differences in gene
induction in the two different types of macrophages, we analyzed
genes upregulated by IFNG, TNF and IL-4 by pairwise SAM
analysis to untreated controls for both thioglycollate and bone
marrow-derived macrophages and compared the genes induced in
the two types of macrophages (Figures 7D–F). Interestingly, a large
number of genes induced by these cytokines were specific for the
type of macrophage used. IFNG induced 209 genes in both TMs
and BMMs, 320 genes only in TMs, and 223 genes only in BMMs
(Figure 7D). Only five genes were induced in both TMs and
BMMs by IL-4, while seven genes were induced only in TMs and
104 genes were induced only in BMMs (Figure 7E). TNF induced
85 genes in both TMs and BMMs, 122 genes only in TMs, and
135 genes only in BMMs (Figure 7F). Table 10 shows specific
genes induced by these cytokines in one or both types of
macrophages. These results suggest that TMs are somewhat more
predisposed to classical activation whereas BMMs are more
predisposed to alternative activation. Future work will define the
basal differences between these two types of macrophages and
determine why they respond differently to different forms of
activation.
Discussion
In this study, we have comprehensively evaluated the
relationship between macrophage activation states induced by
two intracellular protozoan parasites (L. mexicana and T. cruzi), a
bacterial endotoxin (LPS), and various cytokines (IL-4, IL-10,
IFNG, IFNB, TNF). We found that innate activation of mouse
bone marrow-derived macrophages by LPS was most similar to
classical macrophage activation by the cytokines IFNG and TNF.
However, infection by the protozoan pathogens T. cruzi and L.
mexicana elicited responses most similar to alternative activation by
the Th2 cytokine IL-4 and to macrophage deactivation by the
cytokine IL-10. Collectively, these results suggest that the
Table 7. Comparison of genes induced by IFNG, IFNB, and TNF.
Expression ratio (log2) of specific genes induced by one cytokine only
Cytokine .3 2–3 1–2
IFNG Ccl2, Ccl7 Cd83, Ly6a,
Wars
0610038D11Rik, 1110038F14Rik, 1190002H23Rik, 1200009I06Rik, 2210012G02Rik, 2310007H09Rik, 2310016C08Rik,
4921509J17Rik, 4930403L05Rik, 4930427A07Rik, 5031414D18Rik, 9030607L20Rik, 9130209A04Rik, 9930023K05Rik,
A930033M14Rik, Acsl5, Agfg1, Ak3l1, Arhgef3, Armc8, Arrdc4, Atp8a2, B4galt5, BB123696, BC046404, Basp1, Bat2d,
Birc2, Bmi1, Bst2, Btg1, Ccdc25, Ccl3, Cdkn1a, Chmp4b, Ciita, Clcn7, Creb1, Creb5, Crem, Csnk1d, Cxcl16, Cxcl2, Cybb,
Ddit3, Dlk1, Dock4, Egr1, Emr1, Enc1, Etnk1, Fam102b, Fmnl2, Foxred1, Gadd45b, Gigyf2, Glipr2, Gna13, Gsdmd,
Gtf2h1, Gtpbp2, H2-Aa, H2-Ab1, H2-Eb1, H2-T23, H2-T24, Haghl, Hk2, Hspa2, Ier3, Ifrd1, Igf2bp2, Il12rb2, Il1b, Il27,
Inpp5b, Irak2, Irf8, Itgav, Klf4, Lass6, Lcp2, Lrrc14, Lrrc8c, Ly6c1, Maea, Mobkl1a, Mt2, Mtmr14, Myd88, Nfkb1, Nr3c1,
Nrp2, Nsbp1, Obfc2a, Olfr319, P4ha1, Pcmtd1, Pde4b, Pfkp, Pgs1, Phlpp, Plaur, Pmm2, Poldip3, Ppp2r2a, Prpf38a,
Psat1, Psmd2, Ptafr, Rai12, Ralgds, Rars, Rassf1, Rbm7, Saa3, Sco1, Sema3c, Serpinb1a, Sestd1, Sgk1, Slc31a1, Slc3a2,
Slc43a3, Smpdl3b, Snn, Snx20, Spata13, Spred2, Spty2d1, Srgn, St3gal5, St6galnac4, St7, Stam, Stat3, Stk19, Stoml1,
Stradb, Stx2, Tapbp, Tapbpl, Tbc1d9, Tgm2, Tgoln1, Tlr4, Tm9sf4, Tmem132a, Tmem2, Tnfrsf1b, Trps1, Ttc9c, Ubash3b,
Ubd, Ugcg, Wdr20b, Wdr37, Wnt9a, Xkr8, Yme1l1, Zbtb5, Zc3hav1, Zc3hc1, Zfp36, Zfp429, Zfp800, Zyx
IFNB Fcgr1 100040620, 1110018G07Rik, 1700016D18Rik, 1810035L17Rik, 2810474O19Rik, 4932438A13Rik, 5-Mar, 5430427O19Rik,
5730508B09Rik, 6330442E10Rik, 6820401H01Rik, A230046K03Rik, Aadacl1, Aftph, Aipl1, Aldh1l2, Ankle2, Apol9a,
Apol9b, Arid4a, Asb13, Ascc3, Asxl3, Atp10a, Atp11b, Axl, B2m, BB031773, Bco2, C330011K17Rik, C330023M02Rik,
Ccdc86, Ccdc90a, Cdkal1, Chd6, Cnp, Ctla2b, Cycs, Dhh, Dhrs9, E130102H24Rik, Endod1, Epsti1, Erap1, Fam46a,
Fbxw17, Fem1c, Frmd4a, Gcnt2, Glcci1, Gng11, H2-T22, H2-T9, Hfe, Hmgn3, Ier5, Il18, Ilk, Iqwd1, Irf2, Irf9, Itpr1, Kat2b,
Kif5c, Klra8, Kpna4, Lamp2, Ly6e, Ly86, Mllt3, Ms4a6b, Ms4a6c, Mtcp1, Nub1, OTTMUSG00000016703, Oas1c, Oas3,
Olfr843, P2ry14, P2ry6, Papd4, Pi4kb, Plekhf2, Pltp, Pnpt1, Pols, Rab9, Rabep1, Rin2, Rnf139, Rnf31, Rtp4, S1pr2, Sdc3,
Serpinb1c, Serpinb6b, Sgcb, Sgk3, Slamf9, Slc2a8, Slfn10, Smc5, Snw1, Spock2, Stxbp3a, Sumf2, Taok3, Tfb2m,
Timeless, Tlr3, Tlr7, Tlr8, Tmem184b, Tmem209, Tor1aip1, Tor1aip2, Tpst1, Tspan13, Uba7, Usf1, Usp25, Usp42, Vcpip1,
Zc3hav1l, Zcchc6, Zfp281, Zfp295, Zfp319, Zfp455
TNF Ednrb, Gbp2 4833445I07Rik, 9030425E11Rik, 9130221J17Rik, Abcc1, Ahr, C730045O03Rik, Cav1, Chpf, Clec5a, Coq10b, Ddit4,
Dnmt3l, Dusp4, Egr2, Ext1, Gbe1, Gss, Gtf2a1, Herpud1, Hmox1, Irak3, Jag1, Lox, M6pr-ps, Mafg, Mfap3l, Nqo1,
Olfr1272, Olfr214, Orai2, Osbpl3, Pcdh7, Pim3, Prdx6-rs1, Prkar2b, Psmd10, Psmd11, Reln, Rps6ka2, Slc11a1, Slpi, Src,
Syk, Tcfec, Tiparp, Ttc39c, Txnrd1, Ugt1a6a, Unc5b, Vasp, Vcan, Zfp719
Specific genes induced by more than one cytokine (expression ratio varies)
IFNG and
IFNB
1110002E22Rik, 2310058D17Rik, 4933412E12Rik, 9230105E10Rik, AA960436, Adar, B4galt3, BC006779, BC013712, Bambi-ps1, Bfar, Ccl12, Ccnd2, Cd86, Cish,
Clec2d, Csprs, Ctsc, Daxx, Dcp2, Dhx58, Dusp28, Eif2ak2, Fam26f, Fam82a2, Farp2, Fcgr4, Fgl2, Flt1, Fndc3a, Fzd7, Gch1, Gnaq, H2-Q7, H2-T10, Hk1, Ifi205,
Irf7, Katna1, Kdr, Kitl, Ltbp1, Ly6f, Mafk, Mdk, Mitd1, Mlkl, Mov10, Nmi, Nod1, Oas1b, Oas2, Ogfr, Olfr635, Otud1, Parp12, Parp9, Pcgf5, Peli1, Pfkfb3, Pml,
Ppa1, Ppm1k, Ppp1r15b, Prkx, Psmb10, Psmb8, Psmb9, Rasa4, Rgl1, Rnf114, Rnf135, Rnf19b, Rnf34, Samd9l, Samhd1, Serpina3f, Slamf8, Slc28a2, Slc30a1,
Slfn1, Sp110, Stat2, Tap1, Tgs1, Tmcc3, Tnfrsf1a, Tor3a, Trim21, Trim30, Ttc39b, Tyk2, Usp12, Znfx1, Zufsp
IFNG and
TNF
1200003I10Rik, 1200016E24Rik, 2410039M03Rik, Acsl1, Ampd3, Ankrd57, Asns, Ass1, Atf4, Bcl2a1b, Bcl2a1c, Birc3, Car13, Cd1d1, Cdc42ep2, Chac1, Clec4e,
Cxcl1, Denr, Dusp16, Ehd1, Ets2, F10, Fas, Flrt3, Gdap10, Ggct, Gpd2, Gpr141, Herc3, Icam1, Ifi47, Insig1, Jdp2, Lmo4, Lpar1, M6pr, Mcoln2, Mdm2, Mfsd7a,
Mmp14, Mpzl1, Nampt, Nfkbie, Nfkbiz, Nod2, Phlda1, Pim1, Pla2g4a, Ppap2a, Ppap2b, Ppfibp2, Pstpip2, Rab11fip1, Rab12, Rab20, Rel, Rnf14, Rsad2, Slc2a6,
Slc31a2, Slc6a9, Slc7a11, Slfn2, Soat2, Socs3, Spred1, Srxn1, St3gal1, Stam2, Stx11, Tank, Tnf, Tnfaip3, Tnfsf9, Tpm4, Traf1, Trib3, Trim13, Ube2z, Vegfc,
Zc3h12c
IFNB and TNF Mthfr
IFNG and
IFNB and TNF
2010106G01Rik, AI451617, Arg2, Axud1, B230207M22Rik, Casp4, Ccl4, Ccl5, Ccrl2, Cd274, Cd40, Cd69, Ch25h, Clic4, Cmpk2, Csf1, Cxcl10, D14Ertd668e, Ddx58,
Ddx60, Dio2, Dtx3l, Fabp3, Fam46c, Flrt2, Gbp3, Gbp5, Gbp6, Glrp1, Gvin1, Herc5, I830012O16Rik, Ifi203, Ifi204, Ifi35, Ifi44, Ifih1, Ifit1, Ifit2, Ifit3, Igtp, Il15,
Il15ra, Il18bp, Il1rn, Irf1, Irgm1, Irgm2, Isg20, Jak2, Lgals9, Mmp13, Mnda, Mx1, Mx2, Mxd1, Nt5c3, Oas1g, Oasl1, Oasl2, Parp14, Phf11, Pla2g16, Plk2,
Rasgef1b, Rgs1, Ripk2, Rnf213, Slamf7, Slc15a3, Slco3a1, Slfn4, Slfn5, Socs1, Sp100, Stat1, Trafd1, Trex1, Trim34, Ube2l6, Usp18, Zcchc2
doi:10.1371/journal.pntd.0000648.t007
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disparate from the activation state induced by bacterial PAMPs
and Th1 cytokines.
The distinct signature of macrophage transcriptional responses to
kinetoplastids is in contrast to a meta-analysis by Jenner and Young
suggesting that immune cells respond to pathogens with a
generalized common transcriptional program [47]. Jenner and
Young compiled data from 32 published microarray studies,
representing 77 different host-pathogen interactions. A cluster of
511 genes were identifiedthatappeared tobeco-regulated across the
entire dataset, and these genes were termed the ‘‘common host
response.’’ These transcripts were enriched for genes involved in the
immune response against invading pathogens. In this study, we
observedthatthetranscriptionalresponsetothecytokinesIFNGand
TNF is highly related to the response to LPS. A meta-analysis of the
microarrays from this study and the Jenner and Young ‘‘common
host response’’ genes indicated that the cluster of genes shared by
classical activation cytokines and LPS is highly related to the human
common host response genes (Figure S10). This cluster includes
many genes involved inthe immune response, suchas Nfkb, Irf1, Irf7,
Ifit1, Ifit2,a n dMyd88. However, the transcriptional signature of
earlytimepointsduringkinetoplastidinfectionisclearlydistinctfrom
this common host response, highlighting again the difference
between these protozoan parasites and bacterial pathogens.
Table 8. Comparison of biological processes induced by IFNG, IFNB, and TNF.
Biological processes induced by one or more cytokine
P value Biological process Genes
IFNG only 3.81E-07 Immunity and defense C2ta, Ccl2, Ccl3, Ccl7, Cxcl16, Cxcl2, Gadd45b, H2-Aa, H2-Ab1, Hd-D4, H2-Eb1, H2-T24, Haghl,
Hspa2, Ier3, Il12rb2, Il1b, Irak2, Irf8, Lrrc8c, Maea, Myd88, Nfkb1, Phlpp, Plaur, Ppp2r2a, Ptafr,
Saa3, Stat3, Tapbp, Tapbpl, Tnfrsf1b
1.71E-03 T-cell mediated immunity C2ta, Cxcl2, H2-Aa, H2-Ab1, H2-D4, H2-Eb1, H2-T23, H2-T24, Tapbp, Tapbpl
3.76E-03 MHCI-mediated immunity H2-D4, H2-T23, H2-T24, Tapbp, Tapbpl
6.54E-03 MHCII-mediated immunity C2ta, H2-Aa, H2-Ab1, H2-Eb1
IFNB only 3.09E-05 MHCI-mediated immunity B2m, H2-Q5, H2-T22, H2-T9, Hfe
6.83E-03 T-cell mediated immunity B2m, H2-Q5, H2-T22, H2-T9, Hfe, Slamf9
TNF only 9.11E-04 Neurogenesis Ednrb, Egr2, Jag1, Pcdh7, Reln, Rps6ka2, Src, Unc5b
1.74E-03 Ectoderm development Ednrb, Egr2, Jag1, Pcdh7, Reln, Rps6ha2, Src, Unc5b
2.01E-03 Immunity and defense 9030425E11Rik, Abcc1, Ahr, Clec5a, Cog10b, Gbp2, Irak3, Jag1, Prdx6-rs1, Slc11a1, Src, Syk
IFNG and IFNB 1.97E-05 Interferon-mediated immunity Irf7, Nmi, Oas1b, Oas2, Slamf8, Stat2
2.50E-03 Immunity and defense Ccl12, Cd86, Cish, Clec2d, Fcgr3a, H2-Q7, Irf7, Nmi, Nod1, Oas1b, Oas2, Samhd1, Slamf8, Stat2,
Tap1, Tnfrsf1a
2.91E-02 Proteolysis 9230105E10Rik, Ctsc, Pml, Psmb10, Psmb8, Psmb9, Rnf135, Rnf34, Serpina3f, Trim21, Trim30,
Trim34, Usp12
3.66E-02 Protein metabolism and
modification
0710001B24Rik, 9230105E10Rik, B4galt3, Ctsc, Eif2ak, Flt1, Ibrdc3, Katna1, Kdr, Mlkl, Mov10, Pml,
Ppm1k, Prkx, Psmb10, Psmb8, Psmb9, Rnf135, Rnf34, Serpina3f, Tor3a, Trim21, Trim30, Trim 34,
Tyk2, Usp12
IFNG and TNF 1.60E-03 Apoptosis Bcl2a1c, Birc3, Fas, Mdm2, Nod2, Rel, Socs3, Tnf, Traf1, Ube2z
3.23E-03 Inhibition of apoptosis Bcl2a1c, Birc3, Mdm2, Rel, Socs3, Ube2z
1.24E-02 Signal transduction Cxcl1, Dusp16, Edg2, Ets2, Fas, Flrt3, Gpr141, Icam1, M6pr, Pbef1, Ppap2a, Ppap2b, Pstpip2,
Rab12, Rab20, Rel, Rnf14, Socs3, Stam2, Tnf, Traf1, Trib3, Vegfc
IFNG and IFNB and
TNF
1.49E-20 Interferon-mediated immunity Cxcl10, Gbp3, Gbp5, Gbp6, Ifi203, Ifi35, Ifit1, Ifit2, Ifit3, Irf1, Oas1g, Oasl1, Oasl2, Slamf7
9.42E-14 Immunity and defense Ccl4, Ccl5, Ccrl2, Cdc274, Cd40, Cd69, Csf1, Cxcl10, Gbp3, Gbp6, Ifi203, Ifi35, Ifit1, Ifit2, Ifit3, Il15,
Il15ra, Il1rn, Irf1, Lgals9, Oas1g, Oasl1, Oasl2, Rgs1, Slamf7, Slfn5
2.48E-06 Cytokine and chemokine
mediated signaling pathway
Ccl4, Ccl5, Ccrl2, Cd40, Csf1, Cxcl10, Il15, Il15ra, Il1rn, Socs1
2.43E-03 T-cell mediated immunity Cd274, Cd490, Cd69, Ifi35, Il15ra, Slamf7, Slfn5
1.95E-02 Macrophage-mediated immunity Csf1, Cxcl10, Gbp3, Gbp5, Gbp6
4.37E-02 Apoptosis Axud1, Casp5, Ddx58, Ifih1, Il15, Jak2, Lgals9, Ripk2
doi:10.1371/journal.pntd.0000648.t008
Table 9. Genes altered by IL-17 stimulation of bone marrow-
derived macrophages.
Upregulated by IL-17
Gene Name Gene Symbol Fold change
Early growth response 1 Erg1 3.291448
chemokine (C-X-C motif) ligand 1 Cxcl1 2.568791
29-59 oligoadenylate synthetase-like 2 Oasl2 2.419333
PHD finger protein 11 Phf11 2.135998
Ring finger protein 213 Rnf213 2.119956
beta-2 microglobulin B2m 2.069215
ARP3 actin-related protein 3 homolog (yeast) Arp3 2.041713
doi:10.1371/journal.pntd.0000648.t009
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www.plosntds.org 16 March 2010 | Volume 4 | Issue 3 | e648The variability we found between pathogens/pathogen prod-
ucts likely reflect the differences in pattern recognition receptors
utilized by each pathogen. Both protozoan pathogens induced
fewer transcriptional responses than LPS, consistent with previous
microarray studies comparing infection of macrophages by
protozoan and non-protozoan pathogens [19]. However, T. cruzi
induced a number of interferon stimulated genes by 24 h post-
infection, consistent with a recent study by Chessler et al showing
upregulation of interferon-stimulated genes in mice 24 h following
intradermal infection with T. cruzi [22]. The upregulation of
interferon-stimulated genes has been shown to be dependent on
the induction of IFNB via signalling through a novel toll-like
receptor-independent pathway [27,28,48].
The timing of the IFNB-induced gene upregulation in T. cruzi-
infected macrophages is consistent with a previous study
performed by de Avalos et al that implicated T. cruzi escape from
a parasitophorous vacuole into the cytoplasm [21]. A possible
explanation for the differences in responses to the two protozoan
pathogens is that they reside in different intracellular compart-
ments. Leishmania persists in a membrane-bound vacuole within
the cell, while T. cruzi leaves this compartment within hours to
freely replicate in the macrophage cytoplasm. Strikingly, infection
by L. mexicana was so transcriptionally ‘‘silent’’ that the resulting
activation profile was almost indistinguishable from uninfected
cells. This is consistent with several other studies showing limited
responses in various host tissues to various species of Leishmania
[13,14,16,19,20]. One explanation for this silent infection could be
that Leishmania shields itself from host detection by residing within
the parasitophorous vacuole. Another explanation is that L.
mexicana does not express any potent pattern recognition ligands
and therefore cannot activate the host cell. A third explanation is
that the parasite is actively suppressing host responses via binding
of a host receptor or secretion of a virulence factor that interferes
with the inflammatory response. Evidence for this explanation can
be found in previous studies which have shown that Leishmania
species can down-modulate macrophage responses using a variety
of mechanisms [49,50]. L. mexicana amastigotes have been shown
to inhibit IL12 production by disrupting the NF-kB signalling
pathway [51,52]. This has been shown to downregulate the Th1
response in infected mice, leading to increased pathology [53].
Any one or a combination of these factors may play a role in the
transcriptional silence of macrophages infected by L. mexicana.
The protozoan pathogens T. cruzi and L.mexicana produced
transcriptional signatures in infected macrophages that were more
closely related to alternative macrophage activation and macro-
phage deactivation than to classical macrophage activation. This
lends support to studies showing that immunization with the
immunodominant T. cruzi antigen, cruzipain, results in increased
Th2 cytokine secretion [54] and increased arginase activity [55].
The induction of alternatively activated macrophages in T. cruzi
infection results in persistent parasite growth within the cells [56],
suggesting that T. cruzi may evade the host immune response by
promoting alternative macrophage activation. The similarity in
the transcriptional signatures resulting from L. mexicana infection
and IL-10 stimulation is consistent with studies showing that
Leishmania induces IL-10 during infection and that IL-10 plays an
essential role in Leishmania pathogenesis [57,58,59]. These studies
have demonstrated that IL-10 is induced via FcGR ligation by
opsonized parasites [57,59]. Hence, IL-10 may play a role in
dampening the transcriptional response of macrophages to
Leishmania infection.
Our analysis of macrophage responses to cytokine stimulation
revealed stark differences in the activation profile of macrophages
treated with IL-4 relative to macrophages treated with IFNG or
IL-10 (Figure 2 and Table 5). A number of genes have been
previously classified as markers of alternative macrophage
activation [60], but were not identified in our analysis of genes
induced by IL-4 (Table 5). These include Ym1/Ym2 (Chi3l3/
Chi3l4), Fizz1/Relm-alpha (Retnla), and Arg1. Because these genes
are so specifically regulated by IL-4 and are not expressed under
other conditions included in this study, they did not pass our pre-
analysis filter of being ‘present in at least 70% of arrays’ and were
not included in the final dataset used for statistical analysis by
SAM (Dataset S1). This problem highlights a limitation of our
analysis, in that genes that are expressed at very low levels and
induced very specifically by individual cytokines may be filtered
out of the overall analysis. When the data for these specific
markers of alternative activation were extracted from the
unfiltered dataset, they are clearly upregulated in IL-4 stimulated
BMMs, as shown in Figure S6.
By conducting the experiments as time courses over 24 hours
and grouping the time points for analysis, our statistical
comparisons identify genes that are consistently up or down-
regulated. Although important kinetic information is still preserved
upon more detailed analysis (e.g. the identification of a late 24 h
interferon response in T. cruzi infection), such detailed kinetic data
cannot be extracted statistically due to the absence of sufficient
replicates for each time point. Although we have added additional
biological replicates to our kinetoplastid infections, resources have
limited our ability to replicate the time courses for all of the
different cytokines.
Despite the limitations described above, we have for the first
time directly compared global gene expression profiles from
macrophages activated by a diverse group of biologically
important cytokines and pathogens. This dataset will be valuable
to both the parasitology and macrophage biology communities as
a resource for future experiments. Our data identified unique
properties of classically activated, alternatively activated and
deactivated macrophages as well as identified unexpected
relationships between macrophage responses to pathogens and
cytokines.
The functional phenotypes of macrophages in peripheral tissues
depend on both their origin and the cytokine microenvironment to
which they are exposed. In addition to the relationships between
pathogen infection and cytokine stimulation, we have also
evaluated the importance of macrophage origin on these
transcriptional studies. The activation profiles of bone marrow
derived macrophages were distinct from those of identically
treated thioglycollate-elicited macrophages. Discrepancies be-
tween studies investigating macrophage activation can be at least
partly attributed to the use of different types of macrophages.
However, we observed that the two types of macrophage produced
a similar transcriptional response to activation stimuli, indicating
that although baseline gene expression in these macrophages is
Figure 6. Comparison of transcriptional responses to cytokines and intracellular parasites. Unsupervised two-dimensional cluster
analysis was performed on all pathogen and cytokine arrays, using genes exhibiting statistically significant variability between these conditions, as
determined by SAM (n=5414). Arrays in red text highlight the relationship between cytokines involved in classical macrophage activation and the
bacterial antigen LPS. Arrays in blue text highlight the relationship between the protozoan pathogens L. mexicana and T. cruzi and the cytokines IL-4,
IL-10, and IL-17.
doi:10.1371/journal.pntd.0000648.g006
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shared. Further understanding of the underlying mechanism for
the differences between various types of macrophages will be
important to the study of both macrophage biology and host-
pathogen interactions.
Supporting Information
Dataset S1 Dataset including all microarrays represented in
Figures 1–6 of this study (dataset used for SAM analysis).
Found at: doi:10.1371/journal.pntd.0000648.s001 (5.74 MB ZIP)
Dataset S2 List of genes up- or down-regulated by Leishmania
species.
Found at: doi:10.1371/journal.pntd.0000648.s002 (0.05 MB XLS)
Dataset S3 List of genes up- or down-regulated by Trypanosoma
species.
Found at: doi:10.1371/journal.pntd.0000648.s003 (0.18 MB XLS)
Figure S1 Comparative analysis of RNA isolated from fresh
versus frozen bone marrow derived macrophages. RNA from
freshly prepared and cryopreserved BMMs were collected and
hybridized post amplification against each other (cryopreserved
BMM RNA labelled with Cy3 and fresh BMM RNA labelled with
Cy5) on a MEEBO oligonucleotide array. The scatter plot shows
the resulting median fluorescence intensities plotted on the X and
Y axis for fresh and frozen macrophages. The correlation
coefficient (R) is shown.
Found at: doi:10.1371/journal.pntd.0000648.s004 (1.02 MB PDF)
Figure S2 Purity of cultured bone marrow-derived macrophages
(BMMs). The purity of bone marrow derived macrophages that
were used in microarray experiments was confirmed by flow
cytometry analysis using antibodies against CD11b and F4/80. (A)
Histogram showing the percentage of BMMs (99.4%) stained with
CD11b (filled) against unstained BMMs (unfilled). (B) Histogram
showing the percentage of BMMs (93.8%) stained with F4/80
(filled) against unstained BMMs (unfilled).
Found at: doi:10.1371/journal.pntd.0000648.s005 (0.02 MB PDF)
Figure S3 Infection of BMM with L. mexicana. (A) Uninfected
BMMs stained with Diff-Quik. (B) BMMs infected with L. mexicana
at a MOI of 10 and stained with Diff-Quik 24 h post-infection. (C)
BMMs infected with CFSE labelled L. mexicana at a MOI of 10,
visualized by fluorescent microscopy. (D) Flow cytometry analysis
on uninfected BMMs (D) and BMMs infected with CFSE-labelled
L. mexicana at a MOI of 10 (E).
Found at: doi:10.1371/journal.pntd.0000648.s006 (0.49 MB PDF)
Figure S4 Induction of interferon-stimulated genes by T. cruzi.
Quantitative real-time PCR analysis on cDNA from cells infected
with T. cruzi or L. mexicana and from uninfected cells using primers
directed against the interferon-stimulated genes IFIT3 (A) and
IFI205 (B).
Found at: doi:10.1371/journal.pntd.0000648.s007 (0.01 MB PDF)
Figure S5 Comparative analysis of uninfected versus T. cruzi
mock-infected BMMs. RNA from uninfected BMMs and BMMs
treated with supernatant from uninfected BESM cells for 24 h
(mock-infected BMMs) were collected and hybridized post-
amplification against each other (uninfected BMM RNA labelled
with Cy3 and mock-infected BMM RNA labelled with Cy5) on a
MEEBO oligonucleotide array. The scatter plot shows the
resulting median fluorescence intensities plotted on the X and Y
axis for fresh and frozen macrophages. The correlation coefficient
(R) is shown.
Found at: doi:10.1371/journal.pntd.0000648.s008 (0.88 MB PDF)
Figure S6 Induction of alternative macrophage activation
markers by IL-4 stimulated BMMs. Heatmap showing the
expression of genes that are known to be induced by IL-4 in
alternatively activated macrophages, extracted from our IL-4 time
macrophages, TNF stimulation of thioglycollate macrophages, and IL-4 stimulation of thioglycollate macrophages. Arrays clustered based on the type
of macrophage, not the type of cytokine. B. Multiclass SAM analysis was performed on arrays representing IFNG, TNF, and IL-4 stimulation of bone
marrow macrophages. Cluster analysis was performed on genes exhibiting statistically significant differences amongst bone marrow derived
macrophages only (n=168). Arrays clustered based on the type of cytokine, not the type of macrophage. C. Multiclass SAM analysis was performed
on arrays representing IFNG, TNF, and IL-4 stimulation of thioglycollate macrophages. Cluster analysis was performed on genes exhibiting statistically
significant differences amongst thioglycollate macrophages only (n=124). Arrays clustered based on the type of cytokine, not the type of
macrophage. D. Genes induced by IFNG in thioglycollate-elicited macrophages (TM) were compared to genes induced by IFNG in bone marrow-
derived macrophages (BMM). E. Genes induced by IL-4 in TMs were compared to genes induced by IL-4 in BMMs. F. Genes induced by TNF in TMs
were compared to genes induced by TNF in BMMs.
doi:10.1371/journal.pntd.0000648.g007
Table 10. Comparison of genes induced in bone marrow-derived versus thioglycollate-elicited macrophages.
BMM and TM BMM only TM only
IFNG Ccl2, Ccl5, Ccl7, Cd40, Cd69, Cd83, Cd86, Cxcl10, Cxcl16, Fcgr4, Gbp3,
Gbp5, Gbp6, Ifi203, Ifi205, Ifi35, Ifi47, Ifih1, Ifit2, Ifit3, Igf2bp2, Igtp,
Il15ra, Il18bp, Il1rn, Il27, Irf1, Irgm, Jak2, Myd88, Nfkbie, Nfkbiz, Nmi,
Nod1, Nod2, Oas1g, Oas2, Oasl1, Oasl2, Socs1, Socs3, Stat1, Stat2,
Tap1, Tapbpl, Tnfaip3, Tnfrsf1a, Traf1 *
Ccl12, Ccl3, Ccl4, Ccrl2, Cxcl1, Cxcl2, H2-Aa,
H2-Ab1, H2-Eb1, H2-Q7, H2-T10, H2-T23,
H2-T24, Ifi44, Ifit1, Il12rb2, Il15, Il1b, Irf7, Irf8,
Isg20, Mmp13, Mmp14, Nfkb1, Stat3, Tnf,
Tnfrsf1b, Tnfsf9 *
Cxcl3, Cxcl9, Ifi27, Il10ra, Il12a, Il12rb1,
Il13ra1, Il4ra, Irf2, Irf9, Isg15, Nfkb2,
Nfkbia, Tlr1, Tnfsf13b *
IL-4 C030015D21Rik, Cish, Mmp13, Rab15, Rab3il1 Casp6, Cd274, Ch25h, Chst7, Daglb, Dhrs9,
Dusp4, Fcgr2b, Il11ra1, Il1rl2, Il6st, Irf1Pparg,
Socs1, Tlr4 *
2610030P05Rik, B430119L13Rik, Chi3l3,
Hist2h3c2, Mafb, Pdcd1lg2, Zcchc2
TNF Ccl5, Cd69, Cxcl1, Gbp5, Gbp6, Ifi203, Ifih1, Ifit2, Ifit3, Il18bp, Irak3,
Isg20, Jak2, Mmp13, Mx1, Mx2, Nfkbie, Nfkbiz, Nod2, Oasl2, Stat1,
Tnfaip3, Tnfsf9, Traf1 *
Ccl4, Ccrl2, Cd274, Cd40, Cxcl10, Gbp2, Gbp3,
Ifi35, Ifi44, Ifi47, Ifit1, Igtp, Il15, Il15ra, Il1rn,
Irf1, Mmp14, Oas1g, Oasl1, Socs1, Socs3, Tnf,
Trafd1 *
Ccl7, Cd14, Cd86, Cxcl3, Cxcl5, Ifi205,
Il17ra, Il1a, Irf9, Isg15, Oas2, Tlr1, Traf5 *
*Selected genes.
doi:10.1371/journal.pntd.0000648.t010
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to time 0 h, and red indicates upregulated levels expression.
Found at: doi:10.1371/journal.pntd.0000648.s009 (0.01 MB PDF)
Figure S7 Cross induction of classical activation cytokines. (A)
Quantitative real-time PCR analysis of Ifnb expression in cells
stimulated with recombinant TNF and on unstimulated cells. TNF
induced production of Ifnb transcript by 6 h post-stimulation. (B)
Quantitative real-time PCR analysis of Tnf expression in cells
stimulated with recombinant IFNG and IFNB and on unstimu-
lated cells. TNF induced production of Ifnb transcript by 6 h post-
stimulation. IFNG induced expression of Tnf transcript by 2 h
post-stimulation, but IFNB does not. (C) TNF protein secretion
into the supernatant of IFNG-stimulated BMMs 6 h post
treatment was measured by cytometric bead analysis (BD).
Found at: doi:10.1371/journal.pntd.0000648.s010 (0.01 MB PDF)
Figure S8 IL-17 receptor expression on bone marrow-derived
macrophages Cell surface antigen staining was performed on
BMMs using PE-conjugated IL-17R antibody. The histogram
shows cells stained with IL-17R (filled) and cells stained with
IgG2a isotype control (unfilled).
Found at: doi:10.1371/journal.pntd.0000648.s011 (0.01 MB PDF)
Figure S9 Induction of TNF by BMMs activated with LPS.
Intracellular cytokine staining analysis of TNF production in
unstimulated BMMs (A) and BMMs stimulated with 100 ng/uL of
LPS for 4 h (B).
Found at: doi:10.1371/journal.pntd.0000648.s012 (0.02 MB PDF)
Figure S10 Relating mouse macrophage responses to the
human ‘‘common host response’’ Heat map showing significantly
altered genes as determined by multiclass SAM analysis for all
cytokine and pathogen arrays (n=5414). The graph on the right
side represents the frequency that genes in the heat map appear in
the human common host response set determined by Jenner and
Young [47].
Found at: doi:10.1371/journal.pntd.0000648.s013 (0.06 MB PDF)
Methods S1 Methods for Supporting Information materials.
Found at: doi:10.1371/journal.pntd.0000648.s014 (0.06 MB
DOC)
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